Amedeo Smart

Free Medical Literature Service

 

Amedeo

Nuclear Medicine
  Free Subscription

Articles published in
Nucl Med Commun
    May 2024

  1. British Nuclear Medicine Society Spring Meeting 13th - 15th May 2024.
    Nucl Med Commun. 2024;45:420-461.
    >> Share

  2. KIAN ARA H, Alemohammad N, Paymani Z, Ebrahimi M, et al
    Machine learning diagnosis of active Juvenile Idiopathic Arthritis on blood pool [ 99M Tc] Tc-MDP scintigraphy images.
    Nucl Med Commun. 2024;45:355-361.
    >> Share

    April 2024
  3. BESTETTI A, Zangheri B, Gabanelli SV, Parini V, et al
    Union is strength: the combination of radiomics features and 3D-deep learning in a sole model increases diagnostic accuracy in demented patients: a whole brain 18FDG PET-CT analysis.
    Nucl Med Commun. 2024 Apr 18. doi: 10.1097/MNM.0000000000001853.
    >> Share

  4. MUT F, Gaudiano MP, Kapitan M
    Relationship between transient ischemic dilatation and changes in heart rate during gated SPECT acquisition in a low-risk population without perfusion defects.
    Nucl Med Commun. 2024 Apr 15. doi: 10.1097/MNM.0000000000001852.
    >> Share

  5. SAXENA A, Subramanyam P, Sarma M, Bhad B, et al
    18F-FDG PET imaging for treatment response assessment and management guidance in patients with skull base osteomyelitis.
    Nucl Med Commun. 2024 Apr 15. doi: 10.1097/MNM.0000000000001847.
    >> Share

  6. KUMAR P, Arora P, Kumar R, Singh H, et al
    Evaluation of skull bone viability and effect of early surgical intervention in electrical contact burns using 18F-Sodium Fluoride PET-CT imaging.
    Nucl Med Commun. 2024 Apr 9. doi: 10.1097/MNM.0000000000001842.
    >> Share


  7. Role of textural analysis parameters derived from FDG PET/CT in differentiating hepatocellular carcinoma and hepatic metastases: Erratum.
    Nucl Med Commun. 2024;45:353.
    >> Share

  8. GIBBONS T, Perkins A, Barnett J
    Safety, biodistribution and radiation dosimetry of the Arg-Gly-Asp peptide 99m Tc-maraciclatide in healthy volunteers.
    Nucl Med Commun. 2024;45:295-303.
    >> Share

    March 2024
  9. GREEN A, Temsah P, Goldfarb L, Sanfolippo K, et al
    Evaluating appropriateness of 18F-fluciclovine PET/CT relative to standard of care imaging guidelines and the impact of ADT on positivity: a prospective study in 62 Veterans Administration patients at a single institution.
    Nucl Med Commun. 2024 Mar 22. doi: 10.1097/MNM.0000000000001836.
    >> Share

  10. JALILIFAR M, Sadeghi M, Emami-Ardekani A, Geravand K, et al
    Quantifying partial volume effect in SPECT and planar imaging: optimizing region of interest for activity concentration estimation in different sphere sizes.
    Nucl Med Commun. 2024 Mar 20. doi: 10.1097/MNM.0000000000001835.
    >> Share

  11. GONDHANE A, Verma P, Chandak A, Basu S, et al
    Prospective evaluation of 68Ga-NODAGA-RGD PET-CT in patients of carcinoma thyroid with thyroglobulin elevated negative radioiodine scintigraphy (TENIS) with a head-to-head comparison with FDG-PET/CT.
    Nucl Med Commun. 2024 Mar 6. doi: 10.1097/MNM.0000000000001828.
    >> Share

  12. AL-NAHHAS A, Jawad ASM
    F-18-FDG PET-CT in investigating possible malignancy associated with rheumatic disease: beware of excessive radiation.
    Nucl Med Commun. 2024 Mar 6. doi: 10.1097/MNM.0000000000001834.
    >> Share

  13. PARKER JA, Tahir MM, Whitmarsh SR, Sarwar A, et al
    Free mebrofenin clearance.
    Nucl Med Commun. 2024;45:175-180.
    >> Share

    February 2024
  14. FUKUSHIMA Y, Suzuki K, Kim M, Gu W, et al
    Evaluation of bone marrow invasion on the machine learning of 18F-FDG PET texture analysis in lower gingival squamous cell carcinoma.
    Nucl Med Commun. 2024 Feb 19. doi: 10.1097/MNM.0000000000001826.
    >> Share

  15. DIZDAREVIC S, Mccready VR, Blower PJ, Voo SA, et al
    The British nuclear medicine research strategy - the framework.
    Nucl Med Commun. 2024 Feb 19. doi: 10.1097/MNM.0000000000001827.
    >> Share

  16. PEI Y, Wang Z, Hao S, Tong Y, et al
    Analyzing the value of delayed 18F-FDG PET/CT images in diagnosing small colorectal cancer liver metastases in patients with hypothyroidism based on diagnostic accuracy and image standardized uptake value.
    Nucl Med Commun. 2024 Feb 19. doi: 10.1097/MNM.0000000000001825.
    >> Share

  17. JONMARKER O, Nilsson T, Axelsson R, Ericson LH, et al
    [ 18 F]-PSMA-1007 PET imaging optimization and inter-rater reliability - a comparison of three different reconstructions read by four radiologists.
    Nucl Med Commun. 2024 Feb 5. doi: 10.1097/MNM.0000000000001823.
    >> Share

  18. YANG H, Liu X, Wang L, Zhou W, et al
    18F-FDG PET/CT characteristics of IASLC grade 3 invasive adenocarcinoma and the value of 18F-FDG PET/CT for preoperative prediction: a new prognostication model.
    Nucl Med Commun. 2024 Feb 5. doi: 10.1097/MNM.0000000000001819.
    >> Share

  19. WANG M, Peng M, Yang X, Zhang Y, et al
    Preoperative prediction of microsatellite instability status: development and validation of a pan-cancer PET/CT-based radiomics model.
    Nucl Med Commun. 2024 Feb 5. doi: 10.1097/MNM.0000000000001816.
    >> Share

  20. PARGHANE RV, Suralkar T, Nikam D, Basu S, et al
    Evaluation of prostate-specific membrane antigen expression in locally advanced or metastatic breast carcinoma with 68Ga-PSMA-11 positron-emission tomography/computed tomography imaging for potential theranostics.
    Nucl Med Commun. 2024 Feb 5. doi: 10.1097/MNM.0000000000001820.
    >> Share

  21. PUJATTI PB, Dos Santos JPG, Gomes ML, Cardoso MAS, et al
    A comparative study on the quality of in vivo labeled red blood cell radionuclide ventriculography images employing different freeze-dried reagents.
    Nucl Med Commun. 2024;45:155-160.
    >> Share

    January 2024
  22. WECHALEKAR K, Hutt D, Quigley AM, Whelan C, et al
    Recommendations for good clinical practice for DPD bone scintigraphy for cardiac amyloidosis.
    Nucl Med Commun. 2024 Jan 26. doi: 10.1097/MNM.0000000000001796.
    >> Share

  23. VINJAMURI S, Pant V, Bomanji JB, Marengo M, et al
    Assessing nuclear medicine practices: a critical evaluation of QUANUM through a quality improvement perspective and its wider relevance.
    Nucl Med Commun. 2024 Jan 22. doi: 10.1097/MNM.0000000000001815.
    >> Share

  24. OUCHI Y, Kishino T, Miyashita T, Mori T, et al
    Predictive value of local control by 4'-[methyl-11C]-thiotymidine PET volume parameters in p16-negative oropharyngeal, hypopharyngeal, and supraglottic squamous cell carcinoma.
    Nucl Med Commun. 2024 Jan 22. doi: 10.1097/MNM.0000000000001821.
    >> Share

  25. THOMSON WH
    Using VARSKIN+v1.2 to estimate dose from direct skin contamination with radionuclides 223Ra, 212Pb and 225Ac; considerations for Nuclear Medicine staff and associated Personal Protective Equipment (PPE).
    Nucl Med Commun. 2024 Jan 19. doi: 10.1097/MNM.0000000000001808.
    >> Share

  26. CONRAD TJ, Lau HX, Yerkovich ST, Alghamry A, et al
    Ventilation-perfusion scan for diagnosing pulmonary embolism: do chest x-rays matter?
    Nucl Med Commun. 2024 Jan 19. doi: 10.1097/MNM.0000000000001802.
    >> Share

  27. ESEONU K, Oduoza U, Robinson P, Easty M, et al
    Bone scintigraphy with SPECT/CT in paediatric patients with neck and back pain in comparison with other imaging modalities: the experience of a tertiary paediatric referral centre.
    Nucl Med Commun. 2024 Jan 12. doi: 10.1097/MNM.0000000000001811.
    >> Share

  28. MANAFI-FARID R, Mahini M, Mirshahvalad SA, Fallahi B, et al
    Diagnostic value of [68Ga]Ga-Pentixafor PET/CT in malignant melanoma: a pilot study.
    Nucl Med Commun. 2024 Jan 12. doi: 10.1097/MNM.0000000000001806.
    >> Share

  29. KESIM S, Balaban Genc ZC, Soydemir E, Baltacioglu F, et al
    Evaluating therapeutic efficacy of extended shelf-life 90Y glass microspheres in transarterial radioembolization for colorectal cancer: a quantitative FDG PET/CT analysis.
    Nucl Med Commun. 2024 Jan 12. doi: 10.1097/MNM.0000000000001813.
    >> Share

  30. BESTETTI A, Calabrese L, Parini V, Fornara C, et al
    Greater accuracy of radiomics compared to deep learning to discriminate normal subjects from patients with dementia: a whole brain 18FDG PET analysis.
    Nucl Med Commun. 2024 Jan 8. doi: 10.1097/MNM.0000000000001810.
    >> Share

  31. LU Y, Kumbhar S, Liu Y, Vo NJ, et al
    Assessment of infant gonadal dose irradiated from urine-contaminated diapers during diuretic renal scintigraphy.
    Nucl Med Commun. 2024;45:45-50.
    >> Share

  32. KAVURGACI S, Ozmen O, Tatci E, Soyler Y, et al
    Potential role of pre-treatment bone marrow SUVmean to liver SUVmean ratio (BM/L) and comparison of primary tumour FDG uptake with brain FDG uptake in predicting survival in limited-stage lung cancers.
    Nucl Med Commun. 2024;45:77-85.
    >> Share

    December 2023
  33. ONAL C, Guler OC, Torun N, Reyhan M, et al
    Long-term assessment of clinical parameters and positron emission tomography parameters in predicting recurrence in uterine cervical cancer patients receiving definitive chemoradiotherapy.
    Nucl Med Commun. 2023 Dec 28. doi: 10.1097/MNM.0000000000001800.
    >> Share

  34. AGAOGLU SANLI B, Duman E, Gulmez B, Aguloglu N, et al
    Evaluation of the effect of PET/CT Fluorodeoxyglucose inclusion on mortality and survival in operated thymoma patients.
    Nucl Med Commun. 2023 Dec 28. doi: 10.1097/MNM.0000000000001805.
    >> Share

  35. AN S, Huang G, Yu X, Liu J, et al
    The added diagnostic value of 18F-FDG PET/CT radiomic analysis in multiple myeloma patients with negative visual analysis.
    Nucl Med Commun. 2023 Dec 28. doi: 10.1097/MNM.0000000000001809.
    >> Share

  36. BABERWAL P, Sonavane S, Vimalnath KV, Chakravarty R, et al
    Normal physiological distribution and tumor localization of 64CuCl2 in different human malignancies along with semiquantitative scoring: a comparative evaluation with 18Fluorodeoxyglucose (18FDG) PET-CT.
    Nucl Med Commun. 2023 Dec 28. doi: 10.1097/MNM.0000000000001804.
    >> Share

  37. WU KC, Chen SW, Hsieh TC, Yen KY, et al
    Early prediction of distant metastasis in patients with uterine cervical cancer treated with definitive chemoradiotherapy by deep learning using pretreatment [18F]fluorodeoxyglucose positron emission tomography/computed tomography.
    Nucl Med Commun. 2023 Dec 27. doi: 10.1097/MNM.0000000000001799.
    >> Share

  38. JENA SR, Watts A, Aggarwal P, Bachhal V, et al
    68Ga-Pentixafor PET/CT for in-vivo mapping of CXCR4 receptors as potential radiotheranostic targets in soft tissue and bone sarcoma: preliminary results.
    Nucl Med Commun. 2023 Dec 27. doi: 10.1097/MNM.0000000000001803.
    >> Share

  39. XU M, Gu B, Zhang J, Xu X, et al
    Differentiation of cancer of unknown primary and lymphoma in head and neck metastatic poorly differentiated cancer using 18F-FDG PET/CT tumor metabolic heterogeneity index.
    Nucl Med Commun. 2023 Dec 14. doi: 10.1097/MNM.0000000000001797.
    >> Share

  40. SHARMA A, Garg A, Singh M, Sharma MC, et al
    Metabolic imaging in recurrent gliomas: comparative performance of 18F-FDOPA, 18F-fluorocholine and 18F-FDG PET/CT.
    Nucl Med Commun. 2023 Dec 14. doi: 10.1097/MNM.0000000000001795.
    >> Share


  41. British Nuclear Medicine Society Autumn Meeting 2023.
    Nucl Med Commun. 2023;44:1191-1214.
    >> Share

  42. MCMEEKIN HJ, Peters AM, Burniston MT, Vadrucci M, et al
    Quantitative lymphoscintigraphy of the lower limbs for the diagnosis of phlebolymphoedema.
    Nucl Med Commun. 2023;44:1080-1086.
    >> Share

  43. SAGAR S, Kaushik P, Phulia A, Khan D, et al
    Diagnostic accuracy of RBC scintigraphy and CTA for detection of patients with suspected lower gastrointestinal bleeding: a systematic review and meta-analysis.
    Nucl Med Commun. 2023;44:1074-1079.
    >> Share

  44. MARTINEAU PJ, Pelletier-Galarneau M, Slomka P, Goertzen AL, et al
    Optimizing stress-only myocardial perfusion imaging: a clinical prediction model to improve patient selection.
    Nucl Med Commun. 2023;44:1087-1093.
    >> Share

    November 2023
  45. KAUR K, Nagi S, Satapathy S, Aggarwal P, et al
    Estimation of absorbed dose to salivary glands in mCRPC patients undergoing 177 Lu- PSMA-617 radioligand therapy using quantitative SPECT-CT at single time point: a single-center feasibility study.
    Nucl Med Commun. 2023 Nov 20. doi: 10.1097/MNM.0000000000001792.
    >> Share

  46. KALRA S, Tripathi M, Tripathi M, Sonar RS, et al
    Role of FDG PET/CT in definitive and presumed autoimmune encephalitis.
    Nucl Med Commun. 2023 Nov 20. doi: 10.1097/MNM.0000000000001790.
    >> Share

  47. VALKEMA MJ, de Lussanet de la Sabloniere QG, Valkema R, Thomeer MGJ, et al
    18F-FDG PET/MRI for restaging esophageal cancer after neoadjuvant chemoradiotherapy.
    Nucl Med Commun. 2023 Nov 20. doi: 10.1097/MNM.0000000000001793.
    >> Share

    October 2023
  48. KIM SJ, Park CY, Kwon H, Kim YH, et al
    Evaluation of adrenal masses using 18F-FDOPA PET/CT in patients suspected with pheochromocytoma.
    Nucl Med Commun. 2023 Oct 30. doi: 10.1097/MNM.0000000000001781.
    >> Share

  49. COOK GJ, Dickson J, Chicklore S, Dempsey M, et al
    BNMS UK PET standards.
    Nucl Med Commun. 2023 Oct 30. doi: 10.1097/MNM.0000000000001779.
    >> Share

  50. PANAGIOTIDIS E, Papachristou K, Makridou A, Zoglopitou LA, et al
    Review of artificial intelligence clinical applications in Nuclear Medicine.
    Nucl Med Commun. 2023 Oct 30. doi: 10.1097/MNM.0000000000001786.
    >> Share

  51. SAGARA H, Inoue K, Yaku H, Ohsawa A, et al
    A new simpler image quality index based on body size for FDG-PET/CT.
    Nucl Med Commun. 2023 Oct 30. doi: 10.1097/MNM.0000000000001787.
    >> Share

  52. HERNANDEZ MC, Yazaki P, Mortimer JE, Yamauchi D, et al
    Pilot study of HER2 targeted 64Cu-DOTA-tagged PET imaging in gastric cancer patients.
    Nucl Med Commun. 2023 Oct 30. doi: 10.1097/MNM.0000000000001761.
    >> Share

  53. MILOSEVIC A, Styczen H, Haubold J, Kessler L, et al
    Correlation of the apparent diffusion coefficient with the standardized uptake value in meningioma of the skull plane using [68]Ga-DOTATOC PET/MRI.
    Nucl Med Commun. 2023 Oct 12. doi: 10.1097/MNM.0000000000001774.
    >> Share

  54. WANG F, Yuan H, Lv J, Han X, et al
    Stress-only versus rest-stress SPECT MPI in the detection and diagnosis of myocardial ischemia and infarction by machine learning.
    Nucl Med Commun. 2023 Oct 12. doi: 10.1097/MNM.0000000000001782.
    >> Share

  55. ZHAO M, Zan K, Cui X, Chai L, et al
    Investigation of the quarter-dose 18F-FDG total-body PET in routine clinical practice and its clinical value.
    Nucl Med Commun. 2023 Oct 12. doi: 10.1097/MNM.0000000000001777.
    >> Share

  56. RAJU S, Sharma A, Kumar S, Seth A, et al
    Impact of forced diuresis at two different time points on pelvic imaging in prostatic carcinoma with 68Ga-PSMA PET/CT.
    Nucl Med Commun. 2023 Oct 5. doi: 10.1097/MNM.0000000000001771.
    >> Share

  57. PANAGIOTIDIS E, Fragkiadaki V, Papathanasiou N, Kypraios C, et al
    Comparison of 18F-PSMA-1007 and 18F-Choline PET/CT in prostate cancer patients with biochemical recurrence: a phase 3, prospective, multicenter, randomized study.
    Nucl Med Commun. 2023 Oct 2. doi: 10.1097/MNM.0000000000001770.
    >> Share

  58. CISTARO A, Quartuccio N, Piccardo A, Meo G, et al
    Brain positron emission tomography in idiopathic normal-pressure hydrocephalus: new 18F-fluorodeoxyglucose pattern in a long-known syndrome.
    Nucl Med Commun. 2023 Oct 2. doi: 10.1097/MNM.0000000000001763.
    >> Share

  59. MCCREADY R, Dizdarevic S
    Acronyms in Nuclear Medicine (AINM).
    Nucl Med Commun. 2023;44:926.
    >> Share

  60. HAIDAR M, Jazra D, Kassas M
    Challenging false positive findings in 68Ga-FAPI PET: insights from a clinical case.
    Nucl Med Commun. 2023;44:924-926.
    >> Share

  61. AKTAS A, Baskin E, Gencoglu EA, Colak T, et al
    Comparison of parathyroid scintigraphy findings in pediatric and adult patients with secondary hyperparathyroidism.
    Nucl Med Commun. 2023;44:860-863.
    >> Share

  62. GHAEDIAN T, Abdinejad M, Nasrollahi H, Ghaedian M, et al
    Comparing the role of 99m Tc-HYNIC-PSMA-11 and 99m Tc-MDP scintigraphy for the initial staging of intermediate to high-risk prostate cancer.
    Nucl Med Commun. 2023;44:864-869.
    >> Share

  63. MISSIR E, Begley P, Jessop M, Singh N, et al
    Quantitative [123]I-Ioflupane DaTSCAN single-photon computed tomography-computed tomography in Parkinsonism.
    Nucl Med Commun. 2023;44:843-853.
    >> Share

    September 2023
  64. LI P, Zhang Y, Xu T, Zhu J, et al
    Sensitivities evaluation of five radiopharmaceuticals in four common medullary thyroid carcinoma metastatic sites on PET/CT: a network meta-analysis and systematic review.
    Nucl Med Commun. 2023 Sep 29. doi: 10.1097/MNM.0000000000001773.
    >> Share

  65. LUE KH, Chen YH, Chu SC, Chang BS, et al
    A comparison of 18F-FDG PET-based radiomics and deep learning in predicting regional lymph node metastasis in patients with resectable lung adenocarcinoma: a cross-scanner and temporal validation study.
    Nucl Med Commun. 2023 Sep 21. doi: 10.1097/MNM.0000000000001776.
    >> Share

  66. MCQUAID SJ
    The impact of total body PET.
    Nucl Med Commun. 2023 Sep 21. doi: 10.1097/MNM.0000000000001772.
    >> Share

  67. BIN ESSA N, Kaplar Z, Balaji N, Alduraibi A, et al
    PET/CT in treatment response assessment in lung cancer. When should it be recommended?
    Nucl Med Commun. 2023 Sep 14. doi: 10.1097/MNM.0000000000001757.
    >> Share

  68. WAMASING N, Nakamura S, Watanabe H, Kuribayashi A, et al
    Potential of preoperative fluorodeoxyglucose-positron emission tomography/computed tomography to diagnose contralateral lymph node metastases in patients with oral cancer.
    Nucl Med Commun. 2023 Sep 14. doi: 10.1097/MNM.0000000000001765.
    >> Share

  69. WANG H, Xie X, Duan Y, Chai L, et al
    Rabbit systemic glucose metabolism map by total-body dynamic PET/CT technology.
    Nucl Med Commun. 2023 Sep 14. doi: 10.1097/MNM.0000000000001767.
    >> Share

  70. HAIDAR M, Kassas M, Chehade F, Chahinian R, et al
    The role of 18F-FDG-PET/CT in the management of differentiated thyroid cancer.
    Nucl Med Commun. 2023 Sep 14. doi: 10.1097/MNM.0000000000001758.
    >> Share

  71. GHOSH S, Agrawal A, Rangarajan V, Choudhury S, et al
    Evaluation of post-chemotherapy residual seminomatous masses by 18F-fluorodeoxyglucose PET/CT using tumor-to-liver ratio - conundrum or solution?
    Nucl Med Commun. 2023 Sep 14. doi: 10.1097/MNM.0000000000001762.
    >> Share

  72. IRWIN AG
    Scientific support for nuclear medicine.
    Nucl Med Commun. 2023 Sep 14. doi: 10.1097/MNM.0000000000001754.
    >> Share

  73. DANG S, Shivdasani D, Pereira M, Singh N, et al
    Evaluation of treatment response by Hopkins criteria on18F FDG PET-CT in patients of non-small cell lung cancer and its comparison with PERCIST response criteria.
    Nucl Med Commun. 2023 Sep 4. doi: 10.1097/MNM.0000000000001756.
    >> Share

  74. ROGEAU A, Lilburn DML, Kaplar Z, Anderson C, et al
    Identifying and troubleshooting the pitfalls of ictal/interictal brain perfusion SPECT studies.
    Nucl Med Commun. 2023 Sep 4. doi: 10.1097/MNM.0000000000001755.
    >> Share

  75. DONG Y, Sun P, Wu H, Zhong J, et al
    PET/CT imaging fibroblast activation protein in initial colorectal cancer: compared to 18F-FDG PET/CT.
    Nucl Med Commun. 2023 Sep 4. doi: 10.1097/MNM.0000000000001751.
    >> Share

  76. PENG Y, Pan G, Zhao B, Zuo C, et al
    Incremental value of 99m Tc-MIBI single-photon emission computed tomography/computed tomography fusion imaging for the diagnosis of secondary hyperparathyroidism.
    Nucl Med Commun. 2023;44:767-771.
    >> Share

  77. GHAEDIAN T, Abdinejad M, Aieneh P, Ebrahimi S, et al
    Characterization of left ventricular diastolic parameters of gated-single-photon emission computed tomography myocardial perfusion imaging in patients with diabetes and normal myocardial perfusion and systolic function.
    Nucl Med Commun. 2023;44:788-794.
    >> Share

  78. GUVEN O, Karyagar S, Arici S, Ozulker T, et al
    How reliable is the high-volume definition in prostate cancer patients: the potential game-changing role of PSMA.
    Nucl Med Commun. 2023;44:816-824.
    >> Share

    August 2023
  79. KAWAUCHI K, Saito M, Nishigami K, Katoh C, et al
    A convolutional neural network-based system to estimate the arterial plasma radioactivity curve in 18F-FDG dynamic brain PET study.
    Nucl Med Commun. 2023 Aug 30. doi: 10.1097/MNM.0000000000001752.
    >> Share

  80. SAIKOUK H, El Khayati N, Matrane A
    Monte Carlo simulation of SPECT characterization for 223Ra post-injection scintigraphy.
    Nucl Med Commun. 2023 Aug 24. doi: 10.1097/MNM.0000000000001750.
    >> Share

  81. ALHORANI Q, Alkhybari E, Rawashdeh M, Sabarudin A, et al
    Revising and exploring the variations in methodologies for establishing the diagnostic reference levels for paediatric PET/CT imaging.
    Nucl Med Commun. 2023 Aug 24. doi: 10.1097/MNM.0000000000001748.
    >> Share

  82. SANDGREN K, Strandberg SN, Jonsson JH, Grefve J, et al
    Histopathology-validated lesion detection rates of clinically significant prostate cancer with mpMRI, [68Ga]PSMA-11-PET and [11C]Acetate-PET.
    Nucl Med Commun. 2023 Aug 24. doi: 10.1097/MNM.0000000000001743.
    >> Share

  83. ALBERTS I, Seibel S, Xue S, Viscione M, et al
    Investigating the influence of long-axial versus short-axial field of view PET/CT on stage migration in lymphoma and non-small cell lung cancer.
    Nucl Med Commun. 2023 Aug 15. doi: 10.1097/MNM.0000000000001745.
    >> Share

  84. SONG C, Lee JJ, Lee SH, Park JY, et al
    Application of preoperative fluorodeoxyglucose-PET/CT parameters for predicting prognosis of high-grade neuroendocrine cervical cancer.
    Nucl Med Commun. 2023 Aug 14. doi: 10.1097/MNM.0000000000001741.
    >> Share

  85. NAZAR AK, Kalshetty A, Chakravarty R, Chakraborty S, et al
    Exploratory analysis of 64CuCl2 PET-CT imaging in carcinoma prostate and its comparison with 68Ga-PSMA-11 and 18F-FDG PET-CT.
    Nucl Med Commun. 2023 Aug 14. doi: 10.1097/MNM.0000000000001744.
    >> Share

  86. XIE J, Xue B, Bian S, Ji X, et al
    A radiomics nomogram based on 18F-FDG PET/CT and clinical risk factors for the prediction of peritoneal metastasis in gastric cancer.
    Nucl Med Commun. 2023 Aug 14. doi: 10.1097/MNM.0000000000001742.
    >> Share

  87. FARSAVIAN AA, Ghadirzadeh E, Yazdani Charati J, Rahmanzade H, et al
    Evaluation of myocardial viability by a secondary delayed 99mTc-MIBI nuclear scanning in ST-elevation myocardial infarction patients with delay in referral and nonviable myocardium in the first scintigraphy: a preliminary cohort study.
    Nucl Med Commun. 2023;44:697-702.
    >> Share

  88. SALAN A, Menzilcioglu MS, Guler AG, Dogan K, et al
    Comparison of shear wave elastography and dimercaptosuccinic acid renal cortical scintigraphy in pediatric patients.
    Nucl Med Commun. 2023;44:691-696.
    >> Share

  89. WU W, Zhang R, Zhou Y, Wang S, et al
    Impacts of different reconstruction methods on the image quality of cadmium-zinc-telluride-based single photon emission computed tomography/computed tomography pulmonary perfusion imaging.
    Nucl Med Commun. 2023;44:673-681.
    >> Share

    July 2023
  90. FENG Y, Wang P, Chen Y, Dai W, et al
    18F-FDG PET/CT for evaluation of metastases in nonsmall cell lung cancer on the efficacy of immunotherapy.
    Nucl Med Commun. 2023 Jul 31. doi: 10.1097/MNM.0000000000001737.
    >> Share

  91. FERNANDES D, Santos M, Pinheiro M, Duarte H, et al
    Radiopharmaceutical extravasation in bone scintigraphy: a cross-sectional study.
    Nucl Med Commun. 2023 Jul 18. doi: 10.1097/MNM.0000000000001738.
    >> Share

  92. PHULIA A, Sharma A, Sharma JB, Singh TP, et al
    PET/CT imaging in invasive endometriosis: a way to minimize missed diagnosis and reduce invasive interventions.
    Nucl Med Commun. 2023 Jul 18. doi: 10.1097/MNM.0000000000001728.
    >> Share

  93. MICHOPOULOU SK, Dickson JC, Gardner GG, Gee TR, et al
    Brain PET and SPECT imaging and quantification: a survey of the current status in the UK.
    Nucl Med Commun. 2023 Jul 18. doi: 10.1097/MNM.0000000000001736.
    >> Share

  94. ABUQBEITAH M, Demir M, Isikci NI, Kozanlilar B, et al
    A multi-institutional assessment of eye lens dose in nuclear medicine clinics.
    Nucl Med Commun. 2023 Jul 18. doi: 10.1097/MNM.0000000000001727.
    >> Share

  95. EROL FENERCIOGLU O, Beyhan E, Sahin R, Baloglu MC, et al
    The potential role of 68Ga-FAPI-04 PET/CT for screening malignancy in suspected colonic lesions.
    Nucl Med Commun. 2023 Jul 14. doi: 10.1097/MNM.0000000000001734.
    >> Share

  96. FARDANESH R, Beavers K, Jochelson MS, Ulaner GA, et al
    Value of subspecialist second opinion reads of 18F-FDG PET-CT examinations for patients with breast cancer.
    Nucl Med Commun. 2023 Jul 3. doi: 10.1097/MNM.0000000000001726.
    >> Share

  97. AYUBCHA C, Singh SB, Patel KH, Rahmim A, et al
    Machine learning in the positron emission tomography imaging of Alzheimer's disease.
    Nucl Med Commun. 2023 Jul 3. doi: 10.1097/MNM.0000000000001723.
    >> Share

  98. NOTGHI A, James G, Hay PD
    British Nuclear Medicine Society Clinical Guidelines for Gastric empty.
    Nucl Med Commun. 2023;44:563-570.
    >> Share

  99. FONDA US, Leitao ALA, Paiva MMDP, Willegaignon J, et al
    Influence on voxel-based dosimetry: noise effect on absorbed dose dosimetry at single time-point versus sequential single-photon emission computed tomography.
    Nucl Med Commun. 2023;44:596-603.
    >> Share

    June 2023
  100. ZHANG T, Liu Z, Lin L, Han T, et al
    Detection of the gene mutation of epidermal growth factor receptor in lung adenocarcinoma by radiomic features from a small amount of PET data.
    Nucl Med Commun. 2023 Jun 19. doi: 10.1097/MNM.0000000000001718.
    >> Share

  101. MIRSHAHVALAD SA, Manafi-Farid R, Fallahi B, Seifi S, et al
    Diagnostic value of [68Ga]Ga-Pentixafor versus [18F]FDG PET/CTs in non-small cell lung cancer: a head-to-head comparative study.
    Nucl Med Commun. 2023 Jun 12. doi: 10.1097/MNM.0000000000001719.
    >> Share

  102. ZHANG Q, Ren J, Tan X, He M, et al
    18F-fluorodeoxyglucose PET/computed tomography metabolic parameters and sarcopenia in pancreatic cancer.
    Nucl Med Commun. 2023 Jun 12. doi: 10.1097/MNM.0000000000001713.
    >> Share

  103. SARSWAT S, Khan D, Sagar S, Kumar R, et al
    Role of 18F-FDG PET/CT in the diagnosis of benign vs. malignant tumor thrombus.
    Nucl Med Commun. 2023 Jun 5. doi: 10.1097/MNM.0000000000001708.
    >> Share

  104. CHAN TK, Li WI, Lau JHY, Chu KS, et al
    The diagnostic performance of 18fluorine-fluorodeoxyglucose PET for brain metastases: a systematic review and meta-analysis.
    Nucl Med Commun. 2023 Jun 5. doi: 10.1097/MNM.0000000000001715.
    >> Share

  105. LUO Y, Li J, Ma W, Tian X, et al
    Differential diagnosis of lung cancer and tuberculosis based on 18F-fluorodeoxyglucose PET/CT multi-time points imaging.
    Nucl Med Commun. 2023 Jun 5. doi: 10.1097/MNM.0000000000001714.
    >> Share

  106. OWENS C, Fitzhugh A, Harrington K, Paleri V, et al
    Incidentally detected 18F-FDG PET-CT-avid thyroid nodules in patients with advanced malignancy: long-term oncological outcomes from a single-centre retrospective cohort.
    Nucl Med Commun. 2023 Jun 5. doi: 10.1097/MNM.0000000000001720.
    >> Share


  107. British Nuclear Medicine Society Spring Meeting, 22nd - 24th May 2023.
    Nucl Med Commun. 2023;44:518-561.
    >> Share

  108. TAYLOR AT, Fazlur Rahman AKM, Folks RD, Moncayo V, et al
    Computer assisted interpretation of Tc-99m mercaptoacetyltriglycine diuretic scintigraphy enhances resident performance.
    Nucl Med Commun. 2023;44:427-433.
    >> Share

  109. VAN LOEVEZIJN AA, Corion CLS, Zeillemaker AM, Wijers LMH, et al
    Clinical impact of molecular breast imaging as adjunct diagnostic modality in evaluation of indeterminate breast abnormalities and unresolved diagnostic concerns.
    Nucl Med Commun. 2023;44:417-426.
    >> Share

    May 2023

  110. Parametric mapping for 11C-metomidate PET-computed tomography imaging in the study of primary aldosteronism: Retraction.
    Nucl Med Commun. 2023 May 9. doi: 10.1097/MNM.0000000000001711.
    >> Share

  111. ENSIGN SF, Agarwal M, Klanderman M, Badawy M, et al
    Clinical utility of somatostatin receptor positron emission tomography imaging biomarkers for characterization of meningioma among incidental central nervous system lesions.
    Nucl Med Commun. 2023 May 8. doi: 10.1097/MNM.0000000000001706.
    >> Share

  112. VALKEMA MJ, Beukinga RJ, Chatterjee A, Woodruff HC, et al
    External validation of 18F-FDG PET-based radiomic models on identification of residual oesophageal cancer after neoadjuvant chemoradiotherapy.
    Nucl Med Commun. 2023 May 3. doi: 10.1097/MNM.0000000000001707.
    >> Share

  113. VUIJK FA, Feshtali Shahbazi S, Noortman WA, van Velden FHP, et al
    Baseline and early digital [18F]FDG PET/CT and multiparametric MRI contain promising features to predict response to neoadjuvant therapy in locally advanced rectal cancer patients: a pilot study.
    Nucl Med Commun. 2023 May 3. doi: 10.1097/MNM.0000000000001703.
    >> Share

  114. PALLARA T, Annovazzi A, Cristiani R, Vinci F, et al
    Nonvisualized sentinel node on preoperative lymphoscintigraphy in primary cutaneous melanoma: an 11-year retrospective survey.
    Nucl Med Commun. 2023;44:345-350.
    >> Share

    April 2023
  115. SINGH P, Agrawal K, Tripathy SK, Patro SS, et al
    Emerging role of bone scintigraphy single-photon emission computed tomography/computed tomography in foot pain management.
    Nucl Med Commun. 2023 Apr 28. doi: 10.1097/MNM.0000000000001698.
    >> Share

  116. GUZEL Y, Komek H, Can C, Kaplan I, et al
    Comparison of the role of 18F-fluorodeoxyglucose PET/computed tomography and 68Ga-labeled FAP inhibitor-04 PET/CT in patients with malignant mesothelioma.
    Nucl Med Commun. 2023 Apr 28. doi: 10.1097/MNM.0000000000001702.
    >> Share

  117. BASHANK N, Hussein A, Mekawy M, Askar H, et al
    Inter-observer variability between readers in detection of bone metastases comparing different modalities; PET/CT, SPECT/CT and planar bone scintigraphy.
    Nucl Med Commun. 2023 Apr 28. doi: 10.1097/MNM.0000000000001704.
    >> Share

  118. ASKAR HAA, Farghali RM, Mekkaway MA, Bashank NM, et al
    Correlation between metabolic uptake of F-18-FDG-PET/computed tomography and thyroglobulin level in differentiated thyroid cancer patients with suspected recurrence.
    Nucl Med Commun. 2023 Apr 28. doi: 10.1097/MNM.0000000000001705.
    >> Share

  119. AKYOL S, Abuqbeitah M, Demir M
    Assessment of PET/CT: National Electrical Manufacturers Association NU2-2018 Standards versus American Association of Physicists in Medicine Task Group 126.
    Nucl Med Commun. 2023 Apr 17. doi: 10.1097/MNM.0000000000001692.
    >> Share

  120. ELAHMADAWY MA, Ashraf A, Moustafa H, Kotb M, et al
    Prognostic value of initial [18F]FDG PET/computed tomography volumetric and texture analysis-based parameters in patients with head and neck squamous cell carcinoma.
    Nucl Med Commun. 2023 Apr 10. doi: 10.1097/MNM.0000000000001695.
    >> Share

  121. HESSE M, Marchandise S, Gerber B, Roelants V, et al
    Cardiac atrial metabolism quantitative assessment with analog and digital time of flight-PET/computed tomography.
    Nucl Med Commun. 2023 Apr 10. doi: 10.1097/MNM.0000000000001694.
    >> Share

  122. KEPENEK F, Komek H, Can C, Kaplan I, et al
    The prognostic role of whole-body volumetric 68GA-DOTATATE PET/computed tomography parameters in patients with gastroenteropancreatic neuroendocrine tumor treated with 177LU-DOTATATE.
    Nucl Med Commun. 2023 Apr 10. doi: 10.1097/MNM.0000000000001693.
    >> Share

  123. ZHANG J, Jiang YM, Xu AD, Lin S, et al
    Characteristics of fibrotic-foci-like lung adenocarcinoma on 18F-FDG PET/computed tomography and HRCT.
    Nucl Med Commun. 2023 Apr 10. doi: 10.1097/MNM.0000000000001690.
    >> Share

  124. TAN HY, Wong YH, Kasbollah A, Md Shah MN, et al
    Operational nuclear research reactors in the Asia-Pacific with potential for medical radionuclide production.
    Nucl Med Commun. 2023;44:227-243.
    >> Share

    March 2023
  125. CHEN LL, van de Burgt A, Smit F, Audhoe RS, et al
    Investigating the potential added value of [18F]FDG-PET/CT in long COVID patients with persistent symptoms: a proof of concept study.
    Nucl Med Commun. 2023 Mar 24. doi: 10.1097/MNM.0000000000001689.
    >> Share

  126. BALAJI N, Balachandar R, Algodayan S, Lilburn DML, et al
    New impetus for amyloid-PET imaging following the Food and Drug administration approval of a new Alzheimer's disease treatment.
    Nucl Med Commun. 2023 Mar 21. doi: 10.1097/MNM.0000000000001688.
    >> Share

  127. SON SH, Ahn JH, Shin KC, Kim HW, et al
    Brain FDG PET for visualizing the relation between impaired lung function and cognitive decline in lung cancer: a preliminary study.
    Nucl Med Commun. 2023 Mar 21. doi: 10.1097/MNM.0000000000001686.
    >> Share

  128. TANG CYL, Lim GKY, Chua WM, Ng CWQ, et al
    Optimization of Bayesian penalized likelihood reconstruction for 68Ga-prostate-specific membrane antigen-11 PET/computed tomography.
    Nucl Med Commun. 2023 Mar 15. doi: 10.1097/MNM.0000000000001687.
    >> Share

  129. VATSA R, Kaur D, Shekhar SS, Chhabra A, et al
    Comparison of 99mTc-methylenediphosphonate and 68Ga-BPAMD PET/computed tomography imaging in bone metastasis.
    Nucl Med Commun. 2023 Mar 10. doi: 10.1097/MNM.0000000000001685.
    >> Share

  130. HAIDAR M, Al Mahmasani L, Chehade L, Elias C, et al
    Well-differentiated gastro-entero-pancreatic neuroendocrine tumors with positive FDG-PET/CT: a retrospective chart review.
    Nucl Med Commun. 2023 Mar 10. doi: 10.1097/MNM.0000000000001683.
    >> Share

  131. KAMIKAWA Y, Yoshida Y, Kawahara Y
    Effects of point spread function correction and time-of-flight on visual contrast level and pixel values in brain PET images.
    Nucl Med Commun. 2023 Mar 10. doi: 10.1097/MNM.0000000000001681.
    >> Share

  132. FANG Y, Chen S, Xu Y, Qiang M, et al
    Assessment of bone lesions with 18F-FDG PET/MRI in patients with nasopharyngeal carcinoma.
    Nucl Med Commun. 2023 Mar 10. doi: 10.1097/MNM.0000000000001682.
    >> Share

  133. AF BJERKEN S, Axelsson J, Larsson A, Flygare C, et al
    Reliability and validity of visual analysis of [18F]FE-PE2I PET/CT in early Parkinsonian disease.
    Nucl Med Commun. 2023 Mar 3. doi: 10.1097/MNM.0000000000001679.
    >> Share

  134. TSUJIMOTO M, Fukushima A, Kawai H, Watanabe M, et al
    Volume-based 18F-FDG PET analysis of cardiac sarcoidosis using the descending aorta as a reference tissue.
    Nucl Med Commun. 2023 Mar 3. doi: 10.1097/MNM.0000000000001680.
    >> Share

  135. ISHERWOOD AC, Cabral R, Avery G
    Sub 4 minute superfast single-photon emission computed tomography/computed tomography as an add-on for problem-solving in planar bone scintigraphy: a time-saving solution for departments without whole-body single-photon emission computed tomography/co
    Nucl Med Commun. 2023 Mar 3. doi: 10.1097/MNM.0000000000001677.
    >> Share

    February 2023
  136. MISHRA A, Ravina M, Kote R, Kumar A, et al
    Role of textural analysis parameters derived from FDG PET/CT in differentiating hepatocellular carcinoma and hepatic metastases.
    Nucl Med Commun. 2023 Feb 27:e001676. doi: 10.1097/MNM.0000000000001676.
    >> Share

  137. CHAN KC, Perucho JAU, Subramaniam RM, Lee EYP, et al
    Utility of pre-treatment 18F-fluorodeoxyglucose PET radiomic analysis in assessing nodal involvement in cervical cancer.
    Nucl Med Commun. 2023 Feb 27:e001672. doi: 10.1097/MNM.0000000000001672.
    >> Share

  138. LUDWIG DR, Voo S, Morris V
    Fast-track pathway for early diagnosis and management of giant cell arteritis: the combined role of vascular ultrasonography and [18F]-fluorodeoxyglucose PET-computed tomography imaging.
    Nucl Med Commun. 2023 Feb 27:e001670. doi: 10.1097/MNM.0000000000001670.
    >> Share

  139. VUOHIJOKI HE, Constable CJ, Sohlberg AO
    Anatomically guided reconstruction improves lesion quantitation and detectability in bone SPECT/CT.
    Nucl Med Commun. 2023 Feb 21:e001675. doi: 10.1097/MNM.0000000000001675.
    >> Share

  140. PRASHANTH A, Kumar Ravichander S, Eswaran P, Kalyan S, et al
    Diagnostic performance of Ga-68 FAPI 04 PET/CT in colorectal malignancies.
    Nucl Med Commun. 2023 Feb 9. doi: 10.1097/MNM.0000000000001661.
    >> Share

  141. LI D, Tan X, Yuan H, Yao X, et al
    Usefulness of 18F-FDG PET/computed tomography metabolic parameters in predicting sarcopenia and prognosis of treatment-naive patients with non-small cell lung cancer.
    Nucl Med Commun. 2023 Feb 9. doi: 10.1097/MNM.0000000000001669.
    >> Share

  142. ZHANG Z, Sun D, Wang X, Li W, et al
    Using eZIS of SPECT to evaluate the therapeutic effect of carotid endarterectomy.
    Nucl Med Commun. 2023 Feb 9. doi: 10.1097/MNM.0000000000001662.
    >> Share

  143. ARSLAN E, Ergul N, Beyhan E, Erol Fenercioglu O, et al
    The roles of 68Ga-PSMA PET/CT and 18F-FDG PET/CT imaging in patients with triple-negative breast cancer and the association of tissue PSMA and claudin 1, 4, and 7 levels with PET findings.
    Nucl Med Commun. 2023 Feb 9. doi: 10.1097/MNM.0000000000001663.
    >> Share

  144. AGULOGLU N, Aksu A, Unat DS
    Machine learning approach using 18F-FDG PET-based radiomics in differentiation of lung adenocarcinoma with bronchoalveolar distribution and infection.
    Nucl Med Commun. 2023 Feb 9. doi: 10.1097/MNM.0000000000001667.
    >> Share

  145. PU Y, Wang C, Xie R, Zhao S, et al
    Role of 18F-fluorodeoxyglucose PET/computed tomography in the diagnosis and treatment response assessment of primary bone lymphoma.
    Nucl Med Commun. 2023 Feb 2. doi: 10.1097/MNM.0000000000001668.
    >> Share

  146. AKKUS GUNDUZ P, Ozkan E, Kuru Oz D, Soydal C, et al
    Clinical value of fluorine-18-fluorodeoxyglucose PET/MRI for liver metastasis in colorectal cancer: a prospective study.
    Nucl Med Commun. 2023;44:150-160.
    >> Share

  147. HAN Y, Tu L, Zhang Y, Xu L, et al
    A novel urokinase plasminogen activator receptor-targeted peptide-based probe for in-vivo molecular imaging of glioblastoma.
    Nucl Med Commun. 2023;44:142-149.
    >> Share

  148. VAN DER BRUGGEN W, de Geus-Oei LF, Bosmans B, Slart RHJA, et al
    Review of the role of bone-SPECT/CT in tarsal coalitions.
    Nucl Med Commun. 2023;44:115-130.
    >> Share

  149. KOMBER H, Redman S, Graham R, Anane-Adusei S, et al
    Whole-body single photon emission computed tomography/computed tomography for assessment of oncological bone disease - is an extended field of view (from vertex to toes) of clinical value?
    Nucl Med Commun. 2023;44:131-136.
    >> Share

    January 2023
  150. CZIBOR S, Carr R, Redondo F, Auewarakul CU, et al
    Prognostic parameters on baseline and interim [18F]FDG-PET/computed tomography in diffuse large B-cell lymphoma patients.
    Nucl Med Commun. 2023 Jan 30. doi: 10.1097/MNM.0000000000001664.
    >> Share

  151. ZHANG T, Zhang J, Wang H, Li P, et al
    Correlations between glucose metabolism of bone marrow on 18F-fluoro-D-glucose PET/computed tomography and hematopoietic cell populations in autoimmune diseases.
    Nucl Med Commun. 2023 Jan 4. doi: 10.1097/MNM.0000000000001657.
    >> Share

  152. LUE KH, Chen YH, Wu YF, Liu SH, et al
    Influence of the methodological aspects of the dichotomization of total metabolic tumor volume measured through baseline fluorine-18 fluorodeoxyglucose PET on survival prediction in lymphoma.
    Nucl Med Commun. 2023;44:74-80.
    >> Share

  153. PAPANDRIANOS NI, Apostolopoulos ID, Feleki A, Moustakidis S, et al
    AI-based classification algorithms in SPECT myocardial perfusion imaging for cardiovascular diagnosis: a review.
    Nucl Med Commun. 2023;44:1-11.
    >> Share

  154. CHEN YH, Lue KH, Chu SC, Chang BS, et al
    The combined tumor-nodal glycolytic entropy improves survival stratification in nonsmall cell lung cancer with locoregional disease.
    Nucl Med Commun. 2023;44:100-107.
    >> Share

  155. KHURANA A, Garg S, Ravindra SG, Kumar Yadav D, et al
    Multi-time point imaging in 99m Tc-pertechnetate scintigraphy of ectopic gastric mucosa in duplication cysts: value-added services.
    Nucl Med Commun. 2023;44:12-17.
    >> Share

    December 2022
  156. PANAGIOTIDIS E, Pant V, Vinjamuri S
    Review of the role of MRI and 18F-sodium fluoride PET/computed tomography in the characterisation of spinal bone metastases in a cohort of patients with breast cancer.
    Nucl Med Commun. 2022 Dec 27. doi: 10.1097/MNM.0000000000001659.
    >> Share

  157. RAHMANIPOUR E, Ghorbani M, Sadeghi R, Sadraei N, et al
    Diagnostic importance of lung perfusion/ventilation scans in the evaluation of pulmonary embolism in COVID-19 patients: systematic review of the literature.
    Nucl Med Commun. 2022 Dec 27. doi: 10.1097/MNM.0000000000001655.
    >> Share

  158. MALIHA PG, Nolet B, Ebrahim A, Abikhzer G, et al
    Comparing digital to analog prostate-specific membrane antigen-targeted piflufolastat 18F PET/CT in prostate cancer patients in early biochemical failure.
    Nucl Med Commun. 2022 Dec 16. doi: 10.1097/MNM.0000000000001652.
    >> Share

  159. ELLIOTT JEG, Roldao Pereira L, Bell KS, Barnden T, et al
    Evidence of expert clinical practice among nuclear medicine non-medical staff: a scoping review.
    Nucl Med Commun. 2022 Dec 16. doi: 10.1097/MNM.0000000000001650.
    >> Share

  160. BESE T, Bicer E, Tetikli Kosuk A, Akovali B, et al
    The relationship between tumor mean standard uptake value (SUVmax) in preoperative PET/computed tomography and prognostic risk groups in endometrial cancer.
    Nucl Med Commun. 2022 Dec 16. doi: 10.1097/MNM.0000000000001654.
    >> Share

  161. ZHENG W, Liu L, Feng Y, Wang L, et al
    Comparison of 68Ga-FAPI-04 and fluorine-18-fluorodeoxyglucose PET/computed tomography in the detection of ovarian malignancies.
    Nucl Med Commun. 2022 Dec 7. doi: 10.1097/MNM.0000000000001653.
    >> Share

  162. PARK SB, Kim KU, Park YW, Hwang JH, et al
    Application of 18F-fluorodeoxyglucose PET/CT radiomic features and machine learning to predict early recurrence of non-small cell lung cancer after curative-intent therapy.
    Nucl Med Commun. 2022 Dec 2. doi: 10.1097/MNM.0000000000001646.
    >> Share

  163. WILLSON T, Meades R
    Uncollimated gamma camera measurements at two metres to the patient provide a practical and statistically robust method for SeHCAT retention calculation.
    Nucl Med Commun. 2022;43:1247-1253.
    >> Share

  164. ZHANG W, Jia H, Cheng Z, Diao W, et al
    The prognostic value of positron emission tomography/computed tomography-based parameters in locally advanced esophageal squamous cell carcinoma treated with chemoradiation therapy.
    Nucl Med Commun. 2022;43:1239-1246.
    >> Share

  165. YAO X, Tan X, Zhang H, Yuan H, et al
    Relationship between 18F-fluorodeoxyglucose PET/computed tomography metabolic parameters and clinicopathology in endometrial cancer.
    Nucl Med Commun. 2022;43:1233-1238.
    >> Share

  166. AGRAWAL A, Natarajan A, Mithun S, Bakshi G, et al
    Bone metastases in prostate cancer - Gallium-68-labeled prostate-specific membrane antigen or Fluorine 18 sodium fluoride PET/computed tomography - the better tracer?
    Nucl Med Commun. 2022;43:1225-1232.
    >> Share

  167. AGULOGLU N, Aksu A, Unat DS, Akyol M, et al
    The prognostic relationship of 18F-FDG PET/CT metabolic and volumetric parameters in metastatic ALK + NSCLC.
    Nucl Med Commun. 2022;43:1217-1224.
    >> Share

  168. LUO Y, Li J, Huang L, Han Y, et al
    Value of dynamic metabolic curves and artificial neural network prediction models based on 18F-FDG PET/CT multiphase imaging in differentiating nonspecific solitary pulmonary lesions: a pilot study.
    Nucl Med Commun. 2022;43:1204-1216.
    >> Share

  169. MOHAMADIEN NRA, Diab WA, Abd El-Ghani WMA, Abdelhafez YG, et al
    Posttherapy technetium-99m pentavalent dimercaptosuccinic acid brain single-photon emission computed tomography/computed tomography: diagnostic and prognostic values in patients with glioma.
    Nucl Med Commun. 2022;43:1195-1203.
    >> Share

  170. MINAMI Y, Ogura I
    Comparison of maximum and mean standardized uptake values of jaw pathologies with bone SPECT/CT: an especial focus on medication-related osteonecrosis of the jaw.
    Nucl Med Commun. 2022;43:1188-1194.
    >> Share

  171. ABDELHAMED HM, Abdo Soliman MS, Mahmoud AA, Mohamed R, et al
    The utility of technetium-99m pertechnetate thyroid scintigraphy assessing thyroid/salivary ratio as an alternative to thyroid uptake percentage in evaluation of thyroid function, with establishing normal reference values of both parameters: single Eg
    Nucl Med Commun. 2022;43:1181-1187.
    >> Share

  172. CHAUDHARY J, Pandey AK, Sharma PD, Patel C, et al
    Optimizing input parameter of the randomized singular value decomposition algorithm for compressing technetium-99m L,L, ethylenedicysteine renal dynamic study in minimum time preserving clinical information.
    Nucl Med Commun. 2022;43:1171-1180.
    >> Share

  173. PEIX A, Mesquita CT, Gutierrez C, Puente A, et al
    Current status of nuclear cardiology practice in Latin America and the Caribbean, in the era of multimodality cardiac imaging approach: 2022 update.
    Nucl Med Commun. 2022;43:1163-1170.
    >> Share

    November 2022
  174. DIXON J, Dennis J
    Relative contributions to patient effective dose in SPECT-CT hybrid imaging.
    Nucl Med Commun. 2022 Nov 25. doi: 10.1097/MNM.0000000000001648.
    >> Share

  175. DWIVEDI P, Sawant V, Vajarkar V, Vatsa R, et al
    Analysis of image quality by regulating beta function of BSREM reconstruction algorithm and comparison with conventional reconstructions in carcinoma breast studies of PET CT with BGO detector.
    Nucl Med Commun. 2022 Nov 25. doi: 10.1097/MNM.0000000000001631.
    >> Share

  176. EBINC S, Guzel Y, Oruc Z, Komek H, et al
    18F-FDG PET/CT parameters for prediction of response to neoadjuvant therapy and prognosis in rectal cancer.
    Nucl Med Commun. 2022 Nov 25. doi: 10.1097/MNM.0000000000001638.
    >> Share

  177. GUO YH, Huang JW, Wang Y, Lu R, et al
    Value of 99mTc-MIBI SPECT/CT in the localization of recurrent lesions in patients with suspected recurrent parathyroid carcinoma.
    Nucl Med Commun. 2022 Nov 25. doi: 10.1097/MNM.0000000000001641.
    >> Share

  178. ASA S, Ozgur E, Uslu-Besli L, Ince B, et al
    Hybrid Ga-68 prostate-specific membrane antigen PET/MRI in the detection of skeletal metastasis in patients with newly diagnosed prostate cancer: Contribution of each part to the diagnostic performance.
    Nucl Med Commun. 2022 Nov 16. pii: 00006231-990000000-00082.
    >> Share

  179. FERRAZZOLI V, Shankar A, Cockle JV, Tang C, et al
    Mapping glioma heterogeneity using multiparametric 18F-choline PET/MRI in childhood and teenage-young adults.
    Nucl Med Commun. 2022 Nov 16. pii: 00006231-990000000-00085.
    >> Share


  180. British Nuclear Medicine Society Autumn Meeting 2022.
    Nucl Med Commun. 2022;43:1161-1162.
    >> Share

    September 2022
  181. JAROONVANICHKUL V, Leksuwankun S, Vachatimanont S
    Simulated daily readout for maintaining nuclear medicine education in residency training amidst declining case volume: evidence from the COVID-19 pandemic.
    Nucl Med Commun. 2022 Sep 27. pii: 00006231-990000000-00067.
    >> Share

  182. YANG W, Jiao Q, Wang H, Chen W, et al
    Is technetium-99m dimercaptosuccinic acid renal scintigraphy available for predicting vesicoureteral reflux in children with first febrile urinary tract infection under the age of 24 months?
    Nucl Med Commun. 2022 Sep 27. pii: 00006231-990000000-00066.
    >> Share

  183. GRAHAM R, Little D, Cade S, Redman S, et al
    British Nuclear Medicine Society Clinical Guideline for bone scintigraphy.
    Nucl Med Commun. 2022 Sep 27. pii: 00006231-990000000-00065.
    >> Share

  184. YE Y, Yang Y, Gong J, Shao WW, et al
    Comparing the diagnostic accuracy of PET and CMR for the measurement of left ventricular volumes and ejection fraction: a system review and meta-analysis.
    Nucl Med Commun. 2022 Sep 19. pii: 00006231-990000000-00062.
    >> Share

  185. DE ANDRES GOMEZ A, Villalba Ferrer F, Ferrer Rebolleda J, Sanchez Jurado R, et al
    Correlation between MAMMI-PET findings and anatomopathological outcomes in breast cancer patients.
    Nucl Med Commun. 2022 Sep 7. pii: 00006231-990000000-00059.
    >> Share

  186. WANG L, Jiang Y, Zhang Y, Zhou W, et al
    Hepatic superscan on fluorine-18 fluorodeoxyglucose PET/computed tomography imaging: a specific manifestation for diagnosing lymphoma or leukemia involvement.
    Nucl Med Commun. 2022;43:1042-1052.
    >> Share

  187. MA R, Zhao Q, Zhao R, Li J, et al
    Integrated 18F-FDG PET/CT parameter defines metabolic oligometastatic non-small cell lung cancer.
    Nucl Med Commun. 2022;43:1026-1033.
    >> Share

  188. SUNDARAIYA S, T R, Nangia S, Sirohi B, et al
    Role of dynamic and parametric whole-body FDG PET/CT imaging in molecular characterization of primary breast cancer: a single institution experience.
    Nucl Med Commun. 2022;43:1015-1025.
    >> Share

  189. KUROSAWA Y, Kanzaki T, Higuchi T, Suto T, et al
    Usefulness of simulation in optimizing imaging settings for pediatric technetium-99m-dimercaptosuccinic acid single-photon emission computed tomography.
    Nucl Med Commun. 2022;43:987-994.
    >> Share

  190. DHIMAN D, Vatsa R, Sood A
    Challenges and opportunities in developing Actinium-225 radiopharmaceuticals.
    Nucl Med Commun. 2022;43:970-977.
    >> Share

  191. CALISKANER OZTURK B, Atahan E, Kibar A, Sager S, et al
    Investigation of the ongoing pulmonary defects with perfusion-single photon emission computed tomography/computed tomography in patients under anticoagulant therapy for coronavirus disease 2019-induced pulmonary embolism.
    Nucl Med Commun. 2022;43:978-986.
    >> Share

    August 2022
  192. GOKSEL S, Ilkkilic K, Bulbul O, Akdogan E, et al
    Relation of whole-body metabolic tumor volume and total lesion glycolysis on fluorodeoxyglucose PET/computed tomography with clinical and laboratory parameters in newly diagnosed multiple myeloma.
    Nucl Med Commun. 2022 Aug 26. pii: 00006231-990000000-00058.
    >> Share

  193. LIU Y, Hua J, Liu L, Zhang W, et al
    The value of the SUV ratio between lymph node and bone marrow in predicting pelvic lymphatic metastasis of patients with locally advanced cervical cancer: an integrated PET/CT study.
    Nucl Med Commun. 2022 Aug 25. pii: 00006231-990000000-00057.
    >> Share

  194. CHAUDHARY J, Pandey AK, Sharma PD, Jaleel J, et al
    Near-lossless compression of PET/CT images using singular value decomposition.
    Nucl Med Commun. 2022 Aug 22. pii: 00006231-990000000-00056.
    >> Share

  195. ZHANG Q, Xu W
    Correlation analysis of I-131 SPECT/CT uptake parameters with the success ablation treatment of thyroid remnant in patients with low-intermediate-risk differentiated thyroid cancer.
    Nucl Med Commun. 2022 Aug 17. pii: 00006231-990000000-00053.
    >> Share

  196. CAN C, Kepenek F, Komek H, Gundogan C, et al
    Comparison of 18F-FDG PET/CT and 68Ga-FAPI-04 PET/CT in patients with non-small cell lung cancer.
    Nucl Med Commun. 2022 Aug 17. pii: 00006231-990000000-00055.
    >> Share

  197. RABINOWICZ S, Nathan M, Pencharz D, Wagner T, et al
    Ventilation perfusion reporting: the utility of a prior chest radiograph in interpreting ventilation perfusion scans.
    Nucl Med Commun. 2022 Aug 17. pii: 00006231-990000000-00054.
    >> Share

  198. NALLIAH S, Zacho HD
    The value of 68Ga-PSMA-11 PET/CT in patients with prostate cancer and inconclusive standard imaging at primary staging.
    Nucl Med Commun. 2022 Aug 5. pii: 00006231-990000000-00052.
    >> Share

  199. DEILAMI-NEZHAD L, Moghaddam-Banaem L, Sadeghi M
    The preparation, biodistribution, and human's absorbed dose evaluation of Radio-Scandium-HYNIC-TOC for somatostatin-receptor-positive neuroendocrine tumors therapy by animal study.
    Nucl Med Commun. 2022;43:881-891.
    >> Share

  200. ISHIBASHI M, Norikane T, Yamamoto Y, Imajo M, et al
    Correlation of bone marrow 2-deoxy-2-[ 18 F]fluoro-D-glucose uptake with systemic inflammation in patients with newly diagnosed endometrial cancer.
    Nucl Med Commun. 2022;43:916-921.
    >> Share

  201. CHAHID Y, Verberne HJ, Poel E, Hendrikse NH, et al
    Anatomical breast imaging-derived parameters do not provide incremental information in prediction of nonvisualization of sentinel lymph nodes on lymphoscintigraphy.
    Nucl Med Commun. 2022;43:877-880.
    >> Share

  202. MIRSHAHVALAD SA, Chavoshi M, Bahmani Kashkouli M, Fallahi B, et al
    Diagnostic value of lacrimal scintigraphy in the evaluation of lacrimal drainage system obstruction: a systematic review and meta-analysis.
    Nucl Med Commun. 2022;43:860-868.
    >> Share

    July 2022
  203. MONSEF A, Ay MR, Sheikhzadeh P, Geramifar P, et al
    Harmonization based on quantitative analysis of standardized uptake value variations across PET/CT scanners: a multicenter phantom study.
    Nucl Med Commun. 2022 Jul 15. pii: 00006231-990000000-00050.
    >> Share

  204. BHOIL A, Seshadri N, Vinjamuri S
    Indeterminate skeletal and lymph node lesion on 18F PSMA 1007 PET/CT scanning: lessons from a review at 12 months with PSMA-RADS.
    Nucl Med Commun. 2022 Jul 14. pii: 00006231-990000000-00049.
    >> Share

  205. BILGE O, Komek H, Kepenek F, Tastan E, et al
    The effect of coronavirus disease 2019 pneumonia on myocardial ischemia detected by single-photon emission computed tomography myocardial perfusion imaging.
    Nucl Med Commun. 2022;43:756-762.
    >> Share

    June 2022
  206. RANJBAR V, Molavipordanjani S, Biabani Ardakani J, Akhlaghi M, et al
    Initial preclinical evaluation of 68Ga-DOTA-(Ser)3-LTVSPWY peptide as a PET radiotracer for glioblastoma targeting and imaging.
    Nucl Med Commun. 2022 Jun 27. pii: 00006231-990000000-00047.
    >> Share

  207. WONG KK, Frey KA, Niedbala J, Kaza RK, et al
    Differences in tumor-to-normal organ SUV ratios measured with 68Ga-DOTATATE PET compared with 177Lu-DOTATATE SPECT in patients with neuroendocrine tumors.
    Nucl Med Commun. 2022 Jun 10. pii: 00006231-990000000-00041.
    >> Share

  208. COSKUN N, Kartal MO, Erdogan AS, Ozdemir E, et al
    Development and validation of a nomogram for predicting the likelihood of metastasis in prostate cancer patients undergoing Ga-68 PSMA PET/CT due to biochemical recurrence.
    Nucl Med Commun. 2022 Jun 7. pii: 00006231-990000000-00040.
    >> Share

  209. LIU Y, Zhang X, Liu J, Zhang J, et al
    Prospective intraindividual comparison of 18F-PSMA-7Q and 18F-DCFPyL PET/CT in patients with newly diagnosed prostate cancer.
    Nucl Med Commun. 2022;43:725-730.
    >> Share

  210. XIONG K, Li S, Yu Y, Duan S, et al
    Pulmonary perfusion imaging and delayed imaging to measure pulmonary capillary permeability in pulmonary contusion.
    Nucl Med Commun. 2022;43:687-693.
    >> Share

  211. HANSEN CL
    The 'ramp filter' artifact in filtered back projection is due to attenuation not ramp filtering.
    Nucl Med Commun. 2022;43:694-700.
    >> Share

    May 2022
  212. PARK PSU, McDonald E, Singh SB, Raynor WY, et al
    The effects of limb laterality and age on the inflammation and bone turnover of the acromioclavicular shoulder joint: 18F-fluorodeoxyglucose and 18F-sodium-fluoride-PET/computed tomography study.
    Nucl Med Commun. 2022 May 30. pii: 00006231-990000000-00038.
    >> Share

  213. TAN H, Mao W, Cao Y, Cai D, et al
    Half-dose versus full-dose 18F-FDG total-body PET/CT in patients with colorectal cancer.
    Nucl Med Commun. 2022 May 30. pii: 00006231-990000000-00037.
    >> Share

  214. PAEZ D, Marengo M, Bomanji J, Dondi M, et al
    Quality improvement initiative of the IAEA in nuclear medicine: a tool to assess staffing needs within the QUANUM framework.
    Nucl Med Commun. 2022 May 18. pii: 00006231-990000000-00033.
    >> Share

  215. ZIRAKCHIAN ZADEH M, Asadollahi S, Kaghazchi F, Raynor WY, et al
    Prognostic significance of conventional and volumetric PET parameters with and without partial volume correction in the assessment of head and neck squamous cell carcinoma.
    Nucl Med Commun. 2022 May 13. pii: 00006231-990000000-00027.
    >> Share

  216. ZHANG A, Meng X, Zhou X, Wang S, et al
    The 68Ga-DOTA-FAPI-04 PET/CT for the differential diagnosis of solitary fibroma of pleura from other chest disease with low uptake of 18F-FDG.
    Nucl Med Commun. 2022 May 13. pii: 00006231-990000000-00028.
    >> Share

  217. HIGASHIGAWA T, Ichikawa Y, Chino S, Nakajima K, et al
    Usefulness of 18F-FDG PET/computed tomography in differentiating between subacute and chronic aortic dissection: initial investigation.
    Nucl Med Commun. 2022 May 13. pii: 00006231-990000000-00030.
    >> Share

  218. LITTLE D, Hardwick M, Graham R, Cheesewright J, et al
    Learning from error: a nuclear medicine events and learning meeting.
    Nucl Med Commun. 2022 May 4. pii: 00006231-990000000-00023.
    >> Share

  219. BRESSER PL, Sathekge MM, Vorster M
    PET/CT features of a novel gallium-68 labelled hypoxia seeking agent in patients diagnosed with tuberculosis: a proof-of-concept study.
    Nucl Med Commun. 2022 May 4. pii: 00006231-990000000-00018.
    >> Share

  220. KARAHAN SEN NP, Alatas O, Gulcu A, Ozdogan O, et al
    The role of volumetric and textural analysis of pretreatment 18F-fluorodeoxyglucose PET/computerized tomography images in predicting complete response to transarterial radioembolization in hepatocellular cancer.
    Nucl Med Commun. 2022 May 4. pii: 00006231-990000000-00016.
    >> Share

  221. KOU Y, Jiang X, Yao Y, Shen J, et al
    Physiological tracer distribution and benign lesion incidental uptake of Al18F-NOTA-FAPI-04 on PET/CT imaging.
    Nucl Med Commun. 2022 May 4. pii: 00006231-990000000-00020.
    >> Share

  222. SIMIONATO PERROTTA F, Ribeiro U Jr, Mester M, Sobroza de Mello E, et al
    Evaluation of the 18F-FDG-PET/CT uptake association with pathological and immunohistochemistry features in esophagogastric adenocarcinoma.
    Nucl Med Commun. 2022 May 4. pii: 00006231-990000000-00022.
    >> Share

  223. IRWIN AG, Turner CL, Redman S
    Report of the 2020 British Nuclear Medicine Society survey of nuclear medicine equipment, workforce and workload.
    Nucl Med Commun. 2022 May 4. pii: 00006231-990000000-00015.
    >> Share

  224. AYDOS U, Sever T, Vural O, Topuz Turkcan B, et al
    Prognostic value of fluorodeoxyglucose positron emission tomography derived metabolic parameters and textural features in pediatric sarcoma.
    Nucl Med Commun. 2022 May 4. pii: 00006231-990000000-00021.
    >> Share


  225. British Nuclear Medicine Society Spring Meeting 2022.
    Nucl Med Commun. 2022;43:577-623.
    >> Share

  226. SAMMARTANO A, Migliari S, Scarlattei M, Baldari G, et al
    Performance and long-term consistency of five Galliform 68Ge/68Ga generators used for clinical Ga-68 preparations over a 4 year period.
    Nucl Med Commun. 2022;43:568-576.
    >> Share

  227. PANDEY AK, Sonker D, Chaudhary J, Jaleel J, et al
    Restoration of Tc-99m methyl diphosphonate bone scan image using Richardson-Lucy algorithm.
    Nucl Med Commun. 2022;43:518-528.
    >> Share

  228. ROSE DS, Rowe JM, Love AE
    Effect of proton pump inhibitors and other commonly prescribed drugs on rescanning of patients undergoing myocardial perfusion imaging: a case-control study.
    Nucl Med Commun. 2022;43:494-501.
    >> Share

  229. DEGTIAROVA G, Claus P, Duchenne J, Schramm G, et al
    Can nuclear imaging accurately detect scar in ischemic cardiac resynchronization therapy candidates?
    Nucl Med Commun. 2022;43:502-509.
    >> Share

    April 2022
  230. CAPELLI G, Campi C, Bao QR, Morra F, et al
    18F-FDG-PET/MRI texture analysis in rectal cancer after neoadjuvant chemoradiotherapy.
    Nucl Med Commun. 2022 Apr 26. pii: 00006231-990000000-00014.
    >> Share

  231. FRANCESCO D, Domenico A, Pietro B, Giulia V, et al
    18F-fluorodeoxyglucose PET and PET/computed tomography for the evaluation of immunoglobulin G4-related disease: a systematic review.
    Nucl Med Commun. 2022 Apr 19. pii: 00006231-990000000-00010.
    >> Share

  232. WANG S, Wang Y, Qin T, Lv Y, et al
    Biodistribution of 89Zr-oxine-labeled human bone marrow-derived mesenchymal stem cells by micro-PET/computed tomography imaging in Sprague-Dawley rats.
    Nucl Med Commun. 2022 Apr 19. pii: 00006231-990000000-00013.
    >> Share

  233. MAZRANI W, Cook GJR, Bomanji J
    Role of 68Ga and 18F PSMA PET/CT and PET/MRI in biochemical recurrence of prostate cancer: a systematic review of prospective studies.
    Nucl Med Commun. 2022 Apr 19. pii: 00006231-990000000-00011.
    >> Share

  234. GHORBANI H, Soltani S, Zakavi SR, Masoudifard A, et al
    Bone scan with technetium 99m-methyl diphosphonate, the missing link in the initial staging of muscle-invasive bladder carcinoma.
    Nucl Med Commun. 2022 Apr 12. pii: 00006231-990000000-00007.
    >> Share

  235. OLDAN JD, Beaty BM, Jewells VL, Muhleman MA, et al
    Qualitative and quantitative methods in post-chemoradiation PET for head and neck cancer.
    Nucl Med Commun. 2022 Apr 12. pii: 00006231-990000000-00008.
    >> Share

  236. KANERIA N, Redman S, Little D, Graham R, et al
    Diagnostic value of single-photon emission computed tomography-CT foot and ankle studies.
    Nucl Med Commun. 2022;43:392-397.
    >> Share

  237. CHHABRA A, Pandey S, Rathore Y, Kaur G, et al
    Nuclear medicine in the management of superficial skin abnormalities and institutional experience.
    Nucl Med Commun. 2022 Apr 1. pii: 00006231-990000000-00003.
    >> Share

  238. TATAR G, Alcin G, Sengul Samanci N, Erol Fenercioglu O, et al
    Role of 18F-FDG PET/CT in the assessment of therapy response and clinical outcome in metastatic renal cell carcinoma treated with tyrosine kinase inhibitors or immunotherapy.
    Nucl Med Commun. 2022 Apr 1. pii: 00006231-990000000-00004.
    >> Share

  239. ZACHO HD, Ravn S, Ejlersen JA, Fledelius J, et al
    Observer experience and accuracy of 18F-sodium-fluoride PET/CT for the diagnosis of bone metastases in prostate cancer.
    Nucl Med Commun. 2022 Apr 1. pii: 00006231-990000000-00005.
    >> Share

    March 2022
  240. HAN J, Song Q, Guo F, Du R, et al
    Evaluation of response to stereotactic body radiation therapy for nonsmall cell lung cancer: PET response criteria in solid tumors versus response evaluation criteria in solid tumors.
    Nucl Med Commun. 2022 Mar 30. pii: 00006231-990000000-00002.
    >> Share

  241. OZKAN E, Orhan K, Soydal C, Kahya Y, et al
    Combined clinical and specific positron emission tomography/computed tomography-based radiomic features and machine-learning model in prediction of thymoma risk groups.
    Nucl Med Commun. 2022 Mar 1. pii: 00006231-900000000-97913.
    >> Share

    February 2022
  242. MOSTAFA R, Abdelsamie Kandeel A, Abd Elkareem M, Nardo L, et al
    Pretherapy 18F-fluorodeoxyglucose positron emission tomography/computed tomography robust radiomic features predict overall survival in non-small cell lung cancer.
    Nucl Med Commun. 2022 Feb 21. pii: 00006231-900000000-97915.
    >> Share

  243. MERTOGLU A, Ucvet A, Balci G, Aksel N, et al
    Correlation of preoperative PET/computer tomography 18F-fluorodeoxyglucose uptake (maximum standardized uptake value) with prognosis in patients with operated lung cancer.
    Nucl Med Commun. 2022 Feb 14. pii: 00006231-900000000-97916.
    >> Share

  244. RATHORE Y, Shukla J, Laroiya I, Deep A, et al
    Development 68Ga trastuzumab Fab and bioevaluation by PET imaging in HER2/neu expressing breast cancer patients.
    Nucl Med Commun. 2022 Feb 7. pii: 00006231-900000000-97918.
    >> Share

  245. WANG Y, Liu H, Yao S, Guan Z, et al
    Using 18F-flurodeoxyglucose and 68Ga-fibroblast activation protein inhibitor PET/CT to evaluate a new periprosthetic joint infection model of rabbit due to Staphylococcus aureus.
    Nucl Med Commun. 2022;43:232-241.
    >> Share

  246. URSO L, Quartuccio N, Caracciolo M, Evangelista L, et al
    Impact on the long-term prognosis of FDG PET/CT in luminal-A and luminal-B breast cancer.
    Nucl Med Commun. 2022;43:212-219.
    >> Share

  247. TAYLOR CA, Shankar A, Gaze MN, Peet C, et al
    Renal protection during 177lutetium DOTATATE molecular radiotherapy in children: a proposal for safe amino acid infusional volume during peptide receptor radionuclide therapy.
    Nucl Med Commun. 2022;43:242-246.
    >> Share

    January 2022
  248. ZHOU Y, Wang S, Wang P, Li N, et al
    Optimization of image reconstruction method of cerebral blood flow perfusion imaging with digital CZT SPECT.
    Nucl Med Commun. 2022 Jan 31. pii: 00006231-900000000-97920.
    >> Share

  249. ZIRAKCHIAN ZADEH M, Ayubcha C, Raynor WY, Werner TJ, et al
    A review of different methods used for quantification and assessment of FDG-PET/CT in multiple myeloma.
    Nucl Med Commun. 2022 Jan 31. pii: 00006231-900000000-97919.
    >> Share

  250. ARVOLA S, Seppanen M, Malaspina S, Matzke S, et al
    Comparison of reprojected bone SPECT/CT and planar bone scintigraphy for the detection of bone metastases in breast and prostate cancer.
    Nucl Med Commun. 2022 Jan 25. pii: 00006231-900000000-97926.
    >> Share

  251. MALAIH AA, Dunn JT, Nygard L, Kovacs DG, et al
    Test-retest repeatability and interobserver variation of healthy tissue metabolism using 18F-FDG PET/CT of the thorax among lung cancer patients.
    Nucl Med Commun. 2022 Jan 25. pii: 00006231-900000000-97925.
    >> Share

  252. GUC ZG, Turgut B, Avci A, Cengiz F, et al
    Predicting pathological response and overall survival in locally advanced gastric cancer patients undergoing neoadjuvant chemotherapy: the role of PET/computed tomography.
    Nucl Med Commun. 2022 Jan 17. pii: 00006231-900000000-97934.
    >> Share

  253. AKSU A, Vural Topuz O, Yilmaz B, Karahan Sen NP, et al
    Prediction of early biochemical response after 177Lu-PSMA radioligand therapy with 68Ga-PSMA PET, a different perspective with quantitative parameters.
    Nucl Med Commun. 2022 Jan 17. pii: 00006231-900000000-97933.
    >> Share

  254. SHAMIM SA, Arora G, Kumar N, Behera A, et al
    Comparison of 99mTc-methyl diphosphonate bone scintigraphy and 68Ga-DOTANOC PET/computed tomography in articular manifestation of rheumatoid arthritis.
    Nucl Med Commun. 2022 Jan 17. pii: 00006231-900000000-97931.
    >> Share

  255. OWAKI Y, Minamishima K, Nakajima K
    Optimization of pediatric FDG-PET/CT examinations based on physical indicators using the SiPM-PET/CT system.
    Nucl Med Commun. 2022 Jan 17. pii: 00006231-900000000-97930.
    >> Share

  256. SAGAR S, Arora G, Damle N, Sharma R, et al
    F-18 DOPA PET/CT in pediatric patients with hyperinsulinemic hypoglycemia: A correlation with genetic analysis.
    Nucl Med Commun. 2022 Jan 17. pii: 00006231-900000000-97928.
    >> Share

  257. LI Y, Wu X, Fang J, Zhao Q, et al
    Evaluation of fluorine-18-fluorodeoxyglucose PET/computed tomography and human epithelial growth factor receptor 2 expression in treatment-naive patients with lung adenocarcinoma.
    Nucl Med Commun. 2022 Jan 17. pii: 00006231-900000000-97927.
    >> Share

  258. ZUCCHETTA P, Lacognata C, Girardi F, Spimpolo A, et al
    [18F]FDG PET/MRI in the follow-up of hepatocellular carcinoma after liver transplantation.
    Nucl Med Commun. 2022 Jan 11. pii: 00006231-900000000-97936.
    >> Share

  259. SUGAWARA H, Ito K, Watanabe H, Morita T, et al
    Clinical usefulness of PET/MRI in differentiating anterior mediastinal masses.
    Nucl Med Commun. 2022;43:92-99.
    >> Share

  260. BEBBINGTON NA, Zacho HD, Holdgaard PC
    Lesion detection in 18F-sodium fluoride bone imaging: a comparison of attenuation-corrected versus nonattenuation-corrected PET reconstructions from modern PET-CT systems.
    Nucl Med Commun. 2022;43:78-85.
    >> Share

  261. METSER U, Eshet Y, Ortega C, Veit-Haibach P, et al
    The association between lesion tracer uptake on 68Ga-DOTATATE PET with morphological response to 177Lu-DOTATATE therapy in patients with progressive metastatic neuroendocrine tumors.
    Nucl Med Commun. 2022;43:73-77.
    >> Share

  262. GUAN L, Zuo R, Wang Z, Xu L, et al
    Associations of whole-body 18F-FDG PET/CT parameters and SCC-Ag level with overall survival in patients with cervical cancer.
    Nucl Med Commun. 2022;43:49-55.
    >> Share

  263. KUAN TW, Shen CC, Chen JC, Tu KY, et al
    Three-dimensional semiquantitative analysis of gastric emptying SPECT.
    Nucl Med Commun. 2022;43:17-23.
    >> Share

  264. HAN YH, Jeong HJ, Lim ST
    Clinical and metabolic parameters for predicting disease progression of gallbladder adenocarcinoma.
    Nucl Med Commun. 2022;43:42-48.
    >> Share

    December 2021
  265. XUE XQ, Yu WJ, Shao XL, Li XF, et al
    Radiomics model based on preoperative 18F-fluorodeoxyglucose PET predicts N2-3b lymph node metastasis in gastric cancer patients.
    Nucl Med Commun. 2021 Dec 23. pii: 00006231-900000000-97939.
    >> Share

  266. HUANG L, Cao Y, Zhou F, Li J, et al
    Lung adenocarcinoma: development of nomograms based on PET/CT images for prediction of epidermal growth factor receptor mutation status and subtypes.
    Nucl Med Commun. 2021 Dec 23. pii: 00006231-900000000-97937.
    >> Share

  267. ISHIMURA M, Norikane T, Mitamura K, Yamamoto Y, et al
    Correlation of epidermal growth factor receptor mutation status and PD-L1 expression with [18F]FDG PET using volume-based parameters in non-small cell lung cancer.
    Nucl Med Commun. 2021 Dec 13. pii: 00006231-900000000-97946.
    >> Share

  268. ABD EL-GAID S, AbdelHafez MN, Mohamed G, Elazab MSS, et al
    Prediction of pathological response using 18F FDG PET/CT derived metabolic parameters in locally advanced breast cancer patients.
    Nucl Med Commun. 2021 Dec 13. pii: 00006231-900000000-97944.
    >> Share

  269. MO SJ, Axelsson J, Stiernman LJ, Larsson A, et al
    VNTR polymorphism in the SLC6A3 gene does not influence dopamine transporter availability measured by [18F]FE-PE2I PET or [123I]FP-Cit SPECT.
    Nucl Med Commun. 2021 Dec 13. pii: 00006231-900000000-97942.
    >> Share

  270. WANG Y, Lin L, Quan W, Li J, et al
    Effect of Bayesian penalty likelihood algorithm on 18F-FDG PET/CT image of lymphoma.
    Nucl Med Commun. 2021 Dec 3. pii: 00006231-900000000-97947.
    >> Share

  271. UCHINOMURA S, Mitamura K, Norikane T, Yamamoto Y, et al
    Distinguishing between primary central nervous system lymphoma and glioblastoma using [18F]fluoromisonidazole and [18F]FDG PET.
    Nucl Med Commun. 2021 Dec 2. pii: 00006231-900000000-97950.
    >> Share

  272. YU H, Lv J, Hu P, Chen S, et al
    Reduction of radiation accumulation in salivary glands through oral vitamin C during 68Ga-PSMA-11 total-body dynamic PET/CT imaging.
    Nucl Med Commun. 2021 Dec 2. pii: 00006231-900000000-97949.
    >> Share

  273. LU P, Sun Y, Liang B, Yu L, et al
    Derivation and validation of a 18F-FDG PET/CT scoring model to predict malignant pleural effusion.
    Nucl Med Commun. 2021 Dec 2. pii: 00006231-900000000-97948.
    >> Share

    November 2021
  274. CHEN Y, Qiu C, Yu W, Shao X, et al
    The relationship between brain glucose metabolism and insulin resistance in subjects with normal cognition - a study based on 18F-FDG PET.
    Nucl Med Commun. 2021 Nov 23. pii: 00006231-900000000-97951.
    >> Share

  275. LIN Z, Xue Q, Lin R, Yao S, et al
    Reference values of mandibular condylar growth activity: a study of SUVmax with quantitative bone SPECT/CT.
    Nucl Med Commun. 2021 Nov 15. pii: 00006231-900000000-97955.
    >> Share

  276. DONDI F, Albano D, Giubbini R, Bertagna F, et al
    18F-FDG PET/CT for the evaluation of male breast cancer: a systematic review.
    Nucl Med Commun. 2021 Nov 15. pii: 00006231-900000000-97954.
    >> Share

  277. COSKUN N, Cagdas B, Eroglu U, Aslan Y, et al
    The impact of 18F-fluorodeoxyglucose PET/computed tomography on clinical staging in bladder cancer.
    Nucl Med Commun. 2021 Nov 15. pii: 00006231-900000000-97953.
    >> Share

  278. ZHANG JH, Zhao J, Fan Y, Fu ZL, et al
    Prognostic significance of pretreatment 18F-fluorodeoxyglucose positron emission tomography/computed tomography (PET/CT) in patients with primary T cell lymphomas.
    Nucl Med Commun. 2021 Nov 15. pii: 00006231-900000000-97952.
    >> Share

  279. PUCHER PH, White A, Padfield O, Davies AR, et al
    Incidence and relevance of clinically indeterminate nonregional lymph nodes in the treatment of oesophageal cancer.
    Nucl Med Commun. 2021;42:1270-1276.
    >> Share

  280. WINIGER A, Perez Lago MDS, Lehnick D, Roos JE, et al
    The value of intravenous contrast medium in PSMA PET/CT imaging in patients with biochemical recurrence of prostate cancer.
    Nucl Med Commun. 2021;42:1239-1246.
    >> Share

  281. SOARES S, Heraghty N, Gulliver N, Peters AM, et al
    75SeHCAT whole body retention for unexplained chronic diarrhoea based on early first whole body counting.
    Nucl Med Commun. 2021;42:1285-1287.
    >> Share

    October 2021
  282. MCCONACHIE P, McKay E, Crane A, Nguyen N, et al
    Accurate measurement of coronary artery calcium in cancer patients using the CT component of PET/CT scans.
    Nucl Med Commun. 2021 Oct 27. pii: 00006231-900000000-97958.
    >> Share

  283. GUNDAVDA MK, Agarwal MG, Singh N, Gupta R, et al
    Can 18F-FDG PET/CT alone or combined with radiology be used to reliably grade cartilage bone neoplasms for surgical decision making?
    Nucl Med Commun. 2021 Oct 20. pii: 00006231-900000000-97961.
    >> Share

  284. TEILER J, Ahl M, Akerlund B, Brismar H, et al
    99mTc-HMPAO-WBC SPECT/CT versus 18F-FDG-WBC PET/CT in chronic prosthetic joint infection: a pilot study.
    Nucl Med Commun. 2021 Oct 20. pii: 00006231-900000000-97960.
    >> Share

  285. PAYNE H, Bomanji J, Bottomley D, Scarsbrook AF, et al
    Impact of 18F-fluciclovine PET/CT on salvage radiotherapy plans for men with recurrence of prostate cancer postradical prostatectomy.
    Nucl Med Commun. 2021 Oct 19. pii: 00006231-900000000-97962.
    >> Share

  286. GUNDOGAN C, Komek H, Can C, Yildirim OA, et al
    Comparison of 18F-FDG PET/CT and 68Ga-FAPI-04 PET/CT in the staging and restaging of gastric adenocarcinoma.
    Nucl Med Commun. 2021 Oct 5. pii: 00006231-900000000-97971.
    >> Share


  287. Evaluation of 68Ga-PSMA PET/CT with Volumetric Parameters for Staging of Prostate Cancer Patients: Erratum.
    Nucl Med Commun. 2021;42:1186.
    >> Share


  288. British Nuclear Medicine Society Autumn Meeting 2021.
    Nucl Med Commun. 2021;42:1162-1185.
    >> Share

  289. URBANO N, Scimeca M, Tavolozza M, Bonanno E, et al
    18F-FDG-PET/CT analysis in hospitalized patients affected by pulmonary disease: The experience of the Nuclear Medicine Unit of "Policlinico Tor Vegata".
    Nucl Med Commun. 2021;42:1104-1111.
    >> Share

  290. TSUCHITANI T, Kitajima K, Takahashi Y, Kotoura N, et al
    Quantitative evaluation of single-photon emission computed tomography findings in lower extremity possible without computed tomography-based attenuation correction.
    Nucl Med Commun. 2021;42:1097-1103.
    >> Share

  291. FLUX G, Buscombe J
    BNMS position statement on molecular radiotherapy.
    Nucl Med Commun. 2021;42:1061-1063.
    >> Share

    September 2021
  292. KARAHAN SEN NP, Aksu A, Bozkurt O, Tuna EB, et al
    Interreader agreement in evaluation of 68Ga-PSMA PET/CT at the time of initial staging: comparison of the three evaluation criteria in the pretreatment risk groups.
    Nucl Med Commun. 2021 Sep 23. pii: 00006231-900000000-97976.
    >> Share

  293. WANG M, Dong S, Zhang R, Sun D, et al
    Impact of reconstruction parameters on spatial resolution and its comparison between cadmium-zinc-telluride SPECT/CT and conventional SPECT/CT.
    Nucl Med Commun. 2021 Sep 23. pii: 00006231-900000000-97973.
    >> Share

  294. JAUREGUI-OSORO M, De Robertis S, Halsted P, Gould SM, et al
    Production of copper-64 using a hospital cyclotron: targetry, purification and quality analysis.
    Nucl Med Commun. 2021;42:1024-1038.
    >> Share

  295. OH M, Choi JH, Kim SO, Lee PH, et al
    Comparison of empagliflozin and sitagliptin therapy on myocardial perfusion reserve in diabetic patients with coronary artery disease.
    Nucl Med Commun. 2021;42:972-978.
    >> Share

  296. BAZZY J, Gadiyaram V, Nguyen BJ, Birgersdotter-Green U, et al
    Gated single-photon emission computed tomography myocardial perfusion imaging phase analysis as an imaging biomarker for mortality prediction in heart failure patients undergoing cardiac resynchronization therapy.
    Nucl Med Commun. 2021;42:990-997.
    >> Share

  297. MALEK H, Samiei N, Yaghoobi N, Bavaghar N, et al
    Assessment of LV diastolic dysfunction in myocardial perfusion imaging: a correlative study with transthoracic echocardiography.
    Nucl Med Commun. 2021;42:979-983.
    >> Share

  298. AGHAEE A, Soltani E, Jangjoo S, Asadi M, et al
    Repeat injection following sentinel node nonvisualization on lymphoscintigraphy images can decrease axillary dissection rate in breast cancer patients.
    Nucl Med Commun. 2021;42:984-989.
    >> Share

  299. GEMMEL F, Van den Broeck B, Vanelstraete S, Van Innis B, et al
    Hybrid imaging of complicating osteomyelitis in the peripheral skeleton.
    Nucl Med Commun. 2021;42:941-950.
    >> Share

  300. TSUBOI K, Nagaki A, Shibutani T, Kawakami Y, et al
    The setting of heartbeat acceptance windows on gated myocardial perfusion single-photon emission computed tomography using CZT camera: effect of left ventricular functional parameters in patients with arrhythmia.
    Nucl Med Commun. 2021;42:1005-1010.
    >> Share

    August 2021
  301. ICHIKAWA H, Onoguchi M, Shibutani T, Kato T, et al
    Optimization of cross-calibration factor for quantitative bone SPECT without attenuation and scatter correction in the lumbar spine: head-to-head comparison with attenuation and scatter correction.
    Nucl Med Commun. 2021 Aug 26. pii: 00006231-900000000-97979.
    >> Share

  302. JIANG C, Ma G, Liu Q, Song S, et al
    The value of preoperative 18F-FDG PET metabolic and volumetric parameters in predicting microvascular invasion and postoperative recurrence of hepatocellular carcinoma.
    Nucl Med Commun. 2021 Aug 26. pii: 00006231-900000000-97978.
    >> Share

  303. DONDI F, Albano D, Giubbini R, Bertagna F, et al
    18F-FDG PET and PET/CT for the evaluation of gastric signet ring cell carcinoma: a systematic review.
    Nucl Med Commun. 2021 Aug 26. pii: 00006231-900000000-97977.
    >> Share

  304. BAE SH, Kim JY, Jung EJ, Lee HS, et al
    The role of fluorodeoxyglucose-PET/computed tomography as a predictor of breast cancer characteristics and prognosis.
    Nucl Med Commun. 2021 Aug 19. pii: 00006231-900000000-97980.
    >> Share

  305. XUE XQ, Wang B, Yu WJ, Zhang FF, et al
    Relationship between total lesion glycolysis of primary lesions based on 18F-FDG PET/CT and lymph node metastasis in gastric adenocarcinoma: a cross-sectional preliminary study.
    Nucl Med Commun. 2021 Aug 17. pii: 00006231-900000000-97984.
    >> Share

  306. O' DOHERTY J, O' Doherty S, Robins EG, Reilhac A, et al
    Parametric mapping for 11C-metomidate PET-computed tomography imaging in the study of primary aldosteronism.
    Nucl Med Commun. 2021 Aug 17. pii: 00006231-900000000-97981.
    >> Share

  307. SHARMA A, Kumar S, Pandey AK, Arora G, et al
    Haralick texture features extracted from Ga-68 PSMA PET/CT to differentiate normal prostate from prostate cancer: a feasibility study.
    Nucl Med Commun. 2021 Aug 17. pii: 00006231-900000000-97987.
    >> Share

  308. KONG E, Choi J
    The new perspective of PET/CT for axillary nodal staging in early breast cancer patients according to ACOSOG Z0011 trial PET/CT axillary staging according to Z0011.
    Nucl Med Commun. 2021 Aug 9. pii: 00006231-900000000-97986.
    >> Share

  309. ORUC Z, Guzel Y, Ebinc S, Komek H, et al
    Efficacy of 68Ga-PSMA PET/CT-derived whole-body volumetric parameters in predicting response to second-generation androgen receptor axis-targeted therapy, and the prognosis in metastatic hormone-refractory prostate cancer patients.
    Nucl Med Commun. 2021 Aug 6. pii: 00006231-900000000-97990.
    >> Share

  310. DE SOUZA SPM, Tobar N, Frasson F, Perini EA, et al
    Head-to-head comparison between 68Ga-PSMA and 18F-FDG-PET/CT in lymphomas: a preliminary analysis.
    Nucl Med Commun. 2021 Aug 6. pii: 00006231-900000000-97989.
    >> Share

  311. KANEKO K, Baba S, Isoda T, Ishioka H, et al
    Compared to conventional PET/CT scanners, silicon-photomultiplier-based PET/CT scanners show higher arterial 18F-FDG uptake in whole-body 18F-FDG-PET/CT.
    Nucl Med Commun. 2021 Aug 3. pii: 00006231-900000000-97992.
    >> Share

  312. TAKAHASHI MES, Mosci C, Duarte GO, Pericole FV, et al
    Intensity of bone involvement: a quantitative 18F-FDG PET/CT evaluation for monitoring outcome of multiple myeloma.
    Nucl Med Commun. 2021 Aug 3. pii: 00006231-900000000-97991.
    >> Share

  313. BRINK A, Libhaber E, Levin M
    Renogram image characteristics and the reproducibility of differential renal function measurement.
    Nucl Med Commun. 2021;42:866-876.
    >> Share

  314. HAHN E, Kammeier A, Burchert W, Lindner O, et al
    Attenuation correction in CZT myocardial perfusion imaging comparison of supine-prone and low-dose CT-corrected supine acquisitions.
    Nucl Med Commun. 2021;42:884-891.
    >> Share

  315. TSUJIMOTO M, Teramoto A, Dosho M, Tanahashi S, et al
    Automated classification of increased uptake regions in bone single-photon emission computed tomography/computed tomography images using three-dimensional deep convolutional neural network.
    Nucl Med Commun. 2021;42:877-883.
    >> Share

    July 2021
  316. YOUNG JD, Jauregui-Osoro M, Wong WL, Cooper MS, et al
    An overview of nuclear medicine research in the UK and the landscape for clinical adoption.
    Nucl Med Commun. 2021 Jul 19. pii: 00006231-900000000-97998.
    >> Share

  317. NORIKANE T, Mitamura K, Yamamoto Y, Hatakeyama T, et al
    Correlation of 4'-[methyl-11C]-thiothymidine PET with Ki-67 immunohistochemistry separately in patients with newly diagnosed and recurrent gliomas.
    Nucl Med Commun. 2021 Jul 19. pii: 00006231-900000000-97996.
    >> Share

  318. OKUDAN B, Coskun N, Seven B, Atalay MA, et al
    Assessment of volumetric parameters derived from 68Ga-PSMA PET/CT in prostate cancer patients with biochemical recurrence: an institutional experience.
    Nucl Med Commun. 2021 Jul 19. pii: 00006231-900000000-97994.
    >> Share

  319. HUA J, Li L, Liu L, Liu Q, et al
    The diagnostic value of metabolic, morphological and heterogeneous parameters of 18F-FDG PET/CT in mediastinal lymph node metastasis of non-small cell lung cancer.
    Nucl Med Commun. 2021 Jul 15. pii: 00006231-900000000-97999.
    >> Share

  320. DUONG MT, Chen YJ, Doot RK, Young AJ, et al
    Astrocyte activation imaging with 11C-acetate and amyloid PET in mild cognitive impairment due to Alzheimer pathology.
    Nucl Med Commun. 2021 Jul 5. pii: 00006231-900000000-98000.
    >> Share

  321. TEILER J, Akerlund B, Brismar H, Savitcheva I, et al
    Dual-tracer approach vs. dual time-point approach in leukocyte scintigraphy in treatment evaluation of persistent chronic prosthetic joint infection.
    Nucl Med Commun. 2021;42:719-724.
    >> Share

    June 2021
  322. KAPSORITAKIS N, Stathaki M, Bourogianni O, Tsaroucha A, et al
    Clinical impact of targeted single-photon emission computed tomography/computed tomography (SPECT/CT) bone scintigraphy on the assessment of bone metastasis in cancer patients.
    Nucl Med Commun. 2021 Jun 18. pii: 00006231-900000000-98001.
    >> Share

  323. NGUYEN TD, Lin D, Hernandez Pampaloni M
    False positive pharmacologic myocardial perfusion SPECT study in the setting of a left bundle branch block.
    Nucl Med Commun. 2021 Jun 7. pii: 00006231-900000000-98006.
    >> Share

  324. IGARASHI C, Yoshii Y, Tashima H, Iwao Y, et al
    Usefulness of PET-guided surgery with 64Cu-labeled cetuximab for resection of intrapancreatic residual tumors in a xenograft mouse model of resectable pancreatic cancer.
    Nucl Med Commun. 2021 Jun 7. pii: 00006231-900000000-98005.
    >> Share

  325. COSKUN N, Okudan B, Uncu D, Kitapci MT, et al
    Baseline 18F-FDG PET textural features as predictors of response to chemotherapy in diffuse large B-cell lymphoma.
    Nucl Med Commun. 2021 Jun 1. pii: 00006231-900000000-98011.
    >> Share

  326. DEV ID, Puranik AD, Purandare NC, Gupta T, et al
    Prognostic significance of 18F-FDG PET/CT parameters in IDH-1 wild-type GBM and correlation with molecular markers.
    Nucl Med Commun. 2021 Jun 1. pii: 00006231-900000000-98010.
    >> Share

  327. AGRAWAL K, Swaroop S, Patro PSS, Tripathy SK, et al
    Comparison of bone SPECT/CT and MRI in detection of pain generator in ankle and foot pain: a retrospective diagnostic study.
    Nucl Med Commun. 2021 Jun 1. pii: 00006231-900000000-98009.
    >> Share

  328. ABOUZIED MM, Alhinti N, AlMuhaideb A, Al Sugair AS, et al
    Extrahepatic metastases from hepatocellular carcinoma: multimodality image evaluation.
    Nucl Med Commun. 2021;42:583-591.
    >> Share

  329. ROSHDY E, ElNaggar M, Atta H, Kandeel A, et al
    Role of post-therapy 99mTc-MIBI single-photon emission computed tomography/computed tomography scan in predicting survival in patients with high-grade glioma.
    Nucl Med Commun. 2021;42:625-632.
    >> Share

  330. TARTAGLIONE G, Foschi N, Recupero SM, Ieria FP, et al
    Advantages of gravity-assisted diuretic renogram: F + 10 (seated position) method.
    Nucl Med Commun. 2021;42:602-610.
    >> Share

  331. TAKALO R, Hytti H, Ihalainen H, Sohlberg A, et al
    Edge-preserving adaptive autoregressive model for Poisson noise reduction.
    Nucl Med Commun. 2021;42:707-710.
    >> Share

    May 2021
  332. ADIN ME, Uazeno H, Isufi E, Pang Y, et al
    Clinical PET/CT utilization during the COVID-19 pandemic: initial experience at Yale University.
    Nucl Med Commun. 2021 May 26. pii: 00006231-900000000-98012.
    >> Share

  333. KURTH J, Kretzschmar J, Aladwan H, Heuschkel M, et al
    Evaluation of [68Ga]Ga-PSMA PET/CT for therapy response assessment of [177Lu]Lu-PSMA radioligand therapy in metastasized castration refractory prostate cancer and correlation with survival.
    Nucl Med Commun. 2021 May 19. pii: 00006231-900000000-98017.
    >> Share

  334. SOYLUOGLU S, Korkmaz U, Ozdemir B, Ustun F, et al
    68Ga-PSMA-I&T-PET/CT interobserver and intraobserver agreement for prostate cancer: a lesion based and subregional comparison study among observers with different levels of experience.
    Nucl Med Commun. 2021 May 17. pii: 00006231-900000000-98026.
    >> Share

  335. DIBBLE EH, Baird GL, Fahey FH, Hyun H, et al
    PET/computed tomography in inpatients: part 1, international survey.
    Nucl Med Commun. 2021 May 17. pii: 00006231-900000000-98024.
    >> Share

  336. MESGUICH C, Hindie E, de Senneville BD, Tlili G, et al
    Improved 18-FDG PET/CT diagnosis of multiple myeloma diffuse disease by radiomics analysis.
    Nucl Med Commun. 2021 May 17. pii: 00006231-900000000-98020.
    >> Share

  337. KARYAGAR S, Guven O, Karyagar SS, Arici S, et al
    Can 68Ga-PSMA PET/CT-derived prostate-specific membrane antigen expression parameters predict prostate-specific antigen response to enzalutamide treatment?
    Nucl Med Commun. 2021 May 6. pii: 00006231-900000000-98030.
    >> Share

  338. LIU Y, Yao X, Wang C, Wang M, et al
    Peptide-based 68Ga-PET radiotracer for imaging CD133 expression in colorectal cancer.
    Nucl Med Commun. 2021 May 6. pii: 00006231-900000000-98029.
    >> Share


  339. Abstracts: British Nuclear Medicine Society Online Spring Meeting 18th-19th May 2021.
    Nucl Med Commun. 2021;42:575-581.
    >> Share

  340. KIM JS, Park CR, Yoon SH, Lee JA, et al
    Improvement of image quality using amplitude-based respiratory gating in PET-computed tomography scanning.
    Nucl Med Commun. 2021;42:553-565.
    >> Share

  341. ADNAN A, Basu S
    Concept proposal for a six-tier integrated dual tracer PET-CT (68Ga-PSMA and FDG) image scoring system ('Pro-PET' score) and examining its potential implications in metastatic castration-resistant prostate carcinoma theranostics and prognosis.
    Nucl Med Commun. 2021;42:566-574.
    >> Share

  342. MATHEW B, Purandare NC, Pramesh CS, Karimundackal G, et al
    Improving accuracy of 18F-fluorodeoxyglucose PET computed tomography to diagnose nodal involvement in non-small cell lung cancer: utility of using various predictive models.
    Nucl Med Commun. 2021;42:535-544.
    >> Share

  343. KOHLENBERG JD, Panda A, Johnson GB, Castro MR, et al
    Radiologic and clinicopathologic characteristics of thyroid nodules with focal 68Ga-DOTATATE PET activity.
    Nucl Med Commun. 2021;42:510-516.
    >> Share

  344. THAKAR A, Sakthivel P, Arunraj ST, Bhalla AS, et al
    Clinical utility of Ga68 DOTANOC PET/CT imaging in juvenile nasal angiofibroma and the PARIS protocol: a preliminary report.
    Nucl Med Commun. 2021;42:517-522.
    >> Share

  345. MINGELS C, Sachpekidis C, Bohn KP, Hunermund JN, et al
    The influence of colour scale in lesion detection and patient-based sensitivity in [68Ga]Ga-PSMA-PET/CT.
    Nucl Med Commun. 2021;42:495-502.
    >> Share

  346. CHEN B, Zhang H, Liu D, Wang X, et al
    Diagnostic performance of 18F-FDG PET/CT for the detection of occult primary tumors in squamous cell carcinoma of unknown primary in the head and neck: a single-center retrospective study.
    Nucl Med Commun. 2021;42:523-527.
    >> Share

  347. SONG Y, Wang PY, Zheng Y, Liu C, et al
    Expression of TIGAR and its correlation with clinicopathology, prognosis, and 18F-FDG PET/CT parameters in patients with resectable pancreatic ductal adenocarcinoma.
    Nucl Med Commun. 2021;42:528-534.
    >> Share

  348. MALIHA PG, Singerman J, Abikhzer G, Probst S, et al
    Physiologic prostate-specific membrane antigen-targeted 18F-DCFPyL uptake in the epididymis head newly appreciated on digital PET/CT.
    Nucl Med Commun. 2021;42:490-494.
    >> Share

  349. SINGH B, Sharma S, Bansal P, Hooda M, et al
    Comparison of the diagnostic utility of 99mTc-PSMA scintigraphy versus 68Ga-PSMA-11 PET/CT in the detection of metastatic prostate cancer and dosimetry analysis: a gamma-camera-based alternate prostate-specific membrane antigen imaging modality.
    Nucl Med Commun. 2021;42:482-489.
    >> Share

  350. AREFNIA M, Masoumi N, Ghodsirad MA, Moghaddam EJ, et al
    Prognostic value of dynamic renal scan with 99mTc-EC in patients with kidney transplantation: a prospective descriptive study.
    Nucl Med Commun. 2021;42:469-475.
    >> Share

  351. HOEKSTRA RJ, Beulens A, Vrijhof EHJEJ, Wyndaele DNJ, et al
    Diagnostic accuracy of 18F-fluciclovine PET/CT in primary lymph node staging of prostate cancer.
    Nucl Med Commun. 2021;42:476-481.
    >> Share

    April 2021
  352. JIANG Y, Hou G, Huo L, Li F, et al
    18F-FDG PET/computed tomography scan in patients with suspicion of recurrent neuroendocrine carcinoma of the cervix.
    Nucl Med Commun. 2021 Apr 27. pii: 00006231-900000000-98032.
    >> Share

  353. KE L, Wu L, Yu J, Meng X, et al
    Feasibility of semiquantitative 18F-fluorodeoxyglucose PET/computed tomography in patients with advanced lung cancer for interim treatment evaluation of combining immunotherapy and chemotherapy.
    Nucl Med Commun. 2021 Apr 21. pii: 00006231-900000000-98033.
    >> Share

  354. KIM JY, Kim JY, Park SB, Kim C, et al
    A retrospective multicenter study of quantitative bone SPECT/CT to predict the surgical removal of the accessory navicular bone.
    Nucl Med Commun. 2021 Apr 16. pii: 00006231-900000000-98034.
    >> Share

  355. WATERSCHOOT R, D'Asseler Y, Goethals I
    Comparison of an in-house acquired brain F-18 FDG PET normal database with commercially available normal data.
    Nucl Med Commun. 2021 Apr 15. pii: 00006231-900000000-98035.
    >> Share

  356. RAUF MS, Khan ZA, Zahir MN, Al-Sweedan S, et al
    Comparison of 18F-labelled fluoro-2-deoxyglucose-PET with conventional computed tomography for staging and response assessment in paediatric and adult patients with nodular lymphocyte-predominant Hodgkin's lymphoma.
    Nucl Med Commun. 2021 Apr 9. pii: 00006231-900000000-98040.
    >> Share

  357. JALEEL J, Tripathi M, Baghel V, Arunraj ST, et al
    F-18 ML-104 tau PET imaging in mild cognitive impairment.
    Nucl Med Commun. 2021 Apr 9. pii: 00006231-900000000-98039.
    >> Share

  358. COSTA IM, Pereira LR, Jessop M, Shawgi M, et al
    Lacrimal scintigraphy BNMS Guidelines.
    Nucl Med Commun. 2021;42:459-467.
    >> Share

  359. AYESA SL, Schembri GP
    Is 67gallium dead? A retrospective review of 67gallium imaging in a single tertiary referral centre.
    Nucl Med Commun. 2021;42:378-388.
    >> Share

  360. ALEXANDRE DJA, Carmo CCM, Romeiro LD, Gutfilen-Schlesinger G, et al
    99mTc-antitumor necrosis factor-alpha scintigraphy for the detection of inflammatory activity in rheumatoid arthritis.
    Nucl Med Commun. 2021;42:389-395.
    >> Share

    March 2021
  361. KUMAR N, Deo S, Bhoriwal S, Sharma A, et al
    Comparison of treatment response assessed by 18F-FDG PET/CT with the histopathological response using tumor regression grading on surgically resected specimen following neoadjuvant chemotherapy in squamous cell carcinoma of esophagus.
    Nucl Med Commun. 2021 Mar 30. pii: 00006231-900000000-98043.
    >> Share

  362. FALAY O, Selcukbiricik F, Tanju S, Erus S, et al
    The prediction of spread through air spaces with preoperative 18F-FDG PET/CT in cases with primary lung adenocarcinoma, its effect on the decision for an adjuvant treatment and its prognostic role.
    Nucl Med Commun. 2021 Mar 30. pii: 00006231-900000000-98042.
    >> Share

  363. MIYAJI N, Miwa K, Motegi K, Yamashita K, et al
    Patient arm position during quantitative bone single-photon emission computed tomography/computed tomography acquisition can affect image quality and quantitative accuracy: a phantom study.
    Nucl Med Commun. 2021;42:267-275.
    >> Share

  364. PURANIK AD, Rangarajan V, Gosavi A, Shetty N, et al
    Prognostic value of imaging-based parameters in patients with intermediate-stage hepatocellular carcinoma undergoing transarterial radioembolization.
    Nucl Med Commun. 2021;42:337-344.
    >> Share

  365. HUANG YC, Hsu CC, Wu YC, Chen HJ, et al
    Effect of fasting duration on myocardial fluorodeoxyglucose uptake in diabetic and nondiabetic patients.
    Nucl Med Commun. 2021;42:300-305.
    >> Share

  366. TUTINO F, Puccini G, Linguanti F, Puccini B, et al
    Baseline metabolic tumor volume calculation using different SUV thresholding methods in Hodgkin lymphoma patients: interobserver agreement and reproducibility across software platforms.
    Nucl Med Commun. 2021;42:284-291.
    >> Share

  367. LIU B, Yu W, Wang J, Shao X, et al
    Incremental value of regional wall motion abnormalities for detecting obstructive coronary artery disease by rest-only electrocardiogram-gated single-photon emission computerized tomography myocardial perfusion imaging in suspected coronary artery dis
    Nucl Med Commun. 2021;42:276-283.
    >> Share

    February 2021
  368. QUARTUCCIO N, Panareo S, Urso L, Sturiale L, et al
    Initial results of the use of a novel semiquantitative parameter in three-phase bone scan to predict 99mTc-HMPAO-labeled leukocyte scintigraphy in patients with unilateral total knee replacement.
    Nucl Med Commun. 2021;42:198-204.
    >> Share

  369. JIANG W, Liu Y, He Z, Zhou Y, et al
    Prognostic value of left ventricular mechanical dyssynchrony in hypertrophic cardiomyopathy patients with low risk of sudden cardiac death.
    Nucl Med Commun. 2021;42:182-189.
    >> Share

  370. BESTETTI A, Cuko B, Gasparini M, De Servi S, et al
    Direct correlation between ischemic burden induced by dipyridamole and stress peak filling rate: a gated perfusion single-photon emission computed tomography study.
    Nucl Med Commun. 2021;42:173-181.
    >> Share

  371. HUANG MS, Chen TW, Liu YS, Wang YS, et al
    The impact of permanent pacemaker implantation on thallium myocardial perfusion examination detecting ischemic heart disease.
    Nucl Med Commun. 2021;42:190-197.
    >> Share

  372. DE NIJS R, Sijtsema ND, Kruis MF, Jensen CV, et al
    Comparison of 81mKrypton and 99mTc-Technegas for ventilation single-photon emission computed tomography in severe chronic obstructive pulmonary disease.
    Nucl Med Commun. 2021;42:160-168.
    >> Share

    January 2021
  373. MOHD ROHANI MF, Zanial AZ, Suppiah S, Phay Phay K, et al
    Bone single-photon emission computed tomography/computed tomography in cancer care in the past decade: a systematic review and meta-analysis as well as recommendations for further work.
    Nucl Med Commun. 2021;42:9-20.
    >> Share

  374. SCHENKE SA, Klett R, Wagner PR, Mott S, et al
    Characteristics of different histological subtypes of thyroid nodules classified with 99mTc-methoxy-isobutyl-isonitrile imaging and Thyroid Imaging Reporting And Data System.
    Nucl Med Commun. 2021;42:73-80.
    >> Share

  375. ZHANG Y, Li B, Yu H, Song J, et al
    The value of skeletal standardized uptake values obtained by quantitative single-photon emission computed tomography-computed tomography in differential diagnosis of bone metastases.
    Nucl Med Commun. 2021;42:63-67.
    >> Share

  376. HEIMANN I, Kuttenberger J, Della Chiesa A, Bhure U, et al
    Monitoring jaw osteomyelitis therapy with single-photon emission computed tomography/computed tomography.
    Nucl Med Commun. 2021;42:51-57.
    >> Share

  377. SHINTO AS, Karuppusamy KK, Kurup RER, Pandiyan A, et al
    Empirical 188Re-HDD/lipiodol intra-arterial therapy based on tumor volume, in patients with solitary inoperable hepatocellular carcinoma.
    Nucl Med Commun. 2021;42:43-50.
    >> Share

    December 2020
  378. JIN J, Wu K, Li X, Yu Y, et al
    Relationship between tumor heterogeneity and volume in cervical cancer: Evidence from integrated fluorodeoxyglucose 18 PET/MR texture analysis.
    Nucl Med Commun. 2020 Dec 14. doi: 10.1097/MNM.0000000000001354.
    >> Share

    September 2020
  379. MAYES CD
    Safe practice ventilation technique in lung scanning for pulmonary embolism.
    Nucl Med Commun. 2020 Sep 15. doi: 10.1097/MNM.0000000000001278.
    >> Share


Free Medical Abstracts
Privacy Policy
Sponsors
Share

© Amedeo 1997-2016